<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="description" content="chevron">
<title>Chevron Catalog • chevron</title>
<script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.2.2/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.2.2/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Chevron Catalog">
<meta property="og:description" content="chevron">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--><link rel="stylesheet" href="../consent.css">
<script src="../consent.js" type="text/javascript" charset="utf-8"></script>
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">chevron</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.2.0.9024</small>

    <div style="width: 140px; margin-left: 0.5rem;"> <small class="nav-text text-muted me-auto">part of</small> <img src="https://github.com/insightsengineering/hex-stickers/blob/main/PNG/nest.png?raw=true" alt="NEST" style="height: 30px;"><a href="https://pharmaverse.org/" class="external-link"><img src="https://github.com/insightsengineering/hex-stickers/blob/main/PNG/pharmaverse.png?raw=true" alt="pharmaverse" style="height: 28px;"></a> </div>
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item">
  <a class="nav-link" href="../articles/chevron.html">Get started</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="active nav-item">
  <a class="nav-link" href="../articles/index.html">Articles</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
<!-- start dropdown for versions --> <li class="nav-item dropdown">
        <a href="#" class="nav-link dropdown-toggle"
          data-bs-toggle="dropdown" role="button"
          aria-expanded="false" aria-haspopup="true"
          id="dropdown-versions">Versions</a> <div class="dropdown-menu" aria-labelledby="dropdown-versions"> <a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/main">main</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/latest-tag">latest-tag</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/release-candidate">release-candidate</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.0-rc1">v0.2.0-rc1</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.5-rc1">v0.1.5-rc1</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.4-rc1">v0.1.4-rc1</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.0">v0.2.0</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.4">v0.1.4</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.3">v0.1.3</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.2">v0.1.2</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.1">v0.1.1</a> </div></li>
<!-- end dropdown for versions -->
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-reports">Reports</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-reports">
    <a class="dropdown-item" href="../coverage-report/">Coverage report</a>
    <a class="dropdown-item" href="../unit-test-report/">Unit test report</a>
  </div>
</li>
      </ul>
<form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off">
</form>

      <ul class="navbar-nav">
<li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/insightsengineering/chevron">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
</div>

    
  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Chevron Catalog</h1>
            
      
      
      <div class="d-none name"><code>chevron_catalog.rmd</code></div>
    </div>

    
    
<div class="section level2">
<h2 id="tables">
<strong>TABLES</strong><a class="anchor" aria-label="anchor" href="#tables"></a>
</h2>
<div class="section level3">
<h3 id="safety-summary-aet01">
<strong>Safety Summary (<code>AET01</code>)</strong><a class="anchor" aria-label="anchor" href="#safety-summary-aet01"></a>
</h3>
<div class="section level4">
<h4 id="safety-summary">
<strong>1. Safety Summary</strong><a class="anchor" aria-label="anchor" href="#safety-summary"></a>
</h4>
<p>The <strong><code>aet01</code></strong> template produces the
standard safety summary.</p>
<div class="sourceCode" id="cb1"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet01</span>, <span class="va">syn_data</span>, arm_var <span class="op">=</span> <span class="st">"ARM"</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                                 A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                                                  (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE                122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of AEs                                              609           622            703      </span></span>
<span><span class="co">#&gt;   Total number of deaths                                       25 (18.7%)    23 (17.2%)      22 (16.7%)  </span></span>
<span><span class="co">#&gt;   Total number of patients withdrawn from study due to an AE    3 (2.2%)      6 (4.5%)        5 (3.8%)   </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one                                                             </span></span>
<span><span class="co">#&gt;     AE with fatal outcome                                      76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;     Serious AE                                                 104 (77.6%)   101 (75.4%)     99 (75.0%)  </span></span>
<span><span class="co">#&gt;     Serious AE leading to withdrawal from treatment             9 (6.7%)      6 (4.5%)       11 (8.3%)   </span></span>
<span><span class="co">#&gt;     Serious AE leading to dose modification/interruption       22 (16.4%)    26 (19.4%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;     Related Serious AE                                         76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;     AE leading to withdrawal from treatment                    27 (20.1%)    26 (19.4%)      30 (22.7%)  </span></span>
<span><span class="co">#&gt;     AE leading to dose modification/interruption               66 (49.3%)    76 (56.7%)      74 (56.1%)  </span></span>
<span><span class="co">#&gt;     Related AE                                                 105 (78.4%)   108 (80.6%)    109 (82.6%)  </span></span>
<span><span class="co">#&gt;     Related AE leading to withdrawal from treatment             6 (4.5%)      12 (9.0%)       8 (6.1%)   </span></span>
<span><span class="co">#&gt;     Related AE leading to dose modification/interruption       29 (21.6%)    38 (28.4%)      38 (28.8%)  </span></span>
<span><span class="co">#&gt;     Severe AE (at greatest intensity)                          91 (67.9%)    90 (67.2%)      93 (70.5%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="safety-summary-with-modified-rows">
<strong>2. Safety Summary with Modified Rows</strong><a class="anchor" aria-label="anchor" href="#safety-summary-with-modified-rows"></a>
</h4>
<p>Analyses under “Total number of patients with at least one” can be
removed, added, or modified by editing the parameter
<code>anl_vars</code>. An analyses here is an abbreviated name of the
analyses of interest, and supported by a variable in <code>ADAE</code>
derived under the condition of interest. The defined analyses currently
include <code>"FATAL"</code>, <code>"SER"</code>, <code>"SERWD"</code>,
<code>"SERDSM"</code>, <code>"RELSER"</code>, <code>"WD"</code>,
<code>"DSM"</code>, <code>"REL"</code>, <code>"RELWD"</code>,
<code>"RELDSM"</code>, and <code>"SEV"</code>. When modification is
made, analyses must be all listed in the parameter
<code>anl_vars</code>. The example below shows adding customized
analyses <code>"RELCTC35"</code>.</p>
<div class="sourceCode" id="cb2"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="va">syn_data</span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">adae</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">adae</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/filter.html" class="external-link">filter</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">ANL01FL</span> <span class="op">==</span> <span class="st">"Y"</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span></span>
<span>    FATAL <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">AESDTH</span> <span class="op">==</span> <span class="st">"Y"</span>, <span class="st">"AE with fatal outcome"</span><span class="op">)</span>,</span>
<span>    SER <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">AESER</span> <span class="op">==</span> <span class="st">"Y"</span>, <span class="st">"Serious AE"</span><span class="op">)</span>,</span>
<span>    SEV <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">ASEV</span> <span class="op">==</span> <span class="st">"SEVERE"</span>, <span class="st">"Severe AE (at greatest intensity)"</span><span class="op">)</span>,</span>
<span>    REL <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">AREL</span> <span class="op">==</span> <span class="st">"Y"</span>, <span class="st">"Related AE"</span><span class="op">)</span>,</span>
<span>    WD <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">AEACN</span> <span class="op">==</span> <span class="st">"DRUG WITHDRAWN"</span>, <span class="st">"AE leading to withdrawal from treatment"</span><span class="op">)</span>,</span>
<span>    DSM <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span></span>
<span>      <span class="va">.data</span><span class="op">$</span><span class="va">AEACN</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"DRUG INTERRUPTED"</span>, <span class="st">"DOSE INCREASED"</span>, <span class="st">"DOSE REDUCED"</span><span class="op">)</span>,</span>
<span>      <span class="st">"AE leading to dose modification/interruption"</span></span>
<span>    <span class="op">)</span>,</span>
<span>    SERWD <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">SER</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">WD</span>, <span class="st">"Serious AE leading to withdrawal from treatment"</span><span class="op">)</span>,</span>
<span>    SERDSM <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">SER</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">DSM</span>, <span class="st">"Serious AE leading to dose modification/interruption"</span><span class="op">)</span>,</span>
<span>    RELSER <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">SER</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">REL</span>, <span class="st">"Related Serious AE"</span><span class="op">)</span>,</span>
<span>    RELWD <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">REL</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">WD</span>, <span class="st">"Related AE leading to withdrawal from treatment"</span><span class="op">)</span>,</span>
<span>    RELDSM <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">REL</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">DSM</span>, <span class="st">"Related AE leading to dose modification/interruption"</span><span class="op">)</span>,</span>
<span>    CTC35 <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">ATOXGR</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"3"</span>, <span class="st">"4"</span>, <span class="st">"5"</span><span class="op">)</span>, <span class="st">"Grade 3-5 AE"</span><span class="op">)</span>,</span>
<span>    CTC45 <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">ATOXGR</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"4"</span>, <span class="st">"5"</span><span class="op">)</span>, <span class="st">"Grade 4/5 AE"</span><span class="op">)</span>,</span>
<span>    RELCTC35 <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">ATOXGR</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"3"</span>, <span class="st">"4"</span>, <span class="st">"5"</span><span class="op">)</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">AEREL</span> <span class="op">==</span> <span class="st">"Y"</span>, <span class="st">"Related Grade 3-5"</span><span class="op">)</span></span>
<span>  <span class="op">)</span></span>
<span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span>DCSREAS <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/reformat.html" class="external-link">reformat</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">DCSREAS</span>, <span class="va">missing_rule</span><span class="op">)</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet01</span>, <span class="va">proc_data</span>, anl_vars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>safety_var <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"FATAL"</span>, <span class="st">"SER"</span>, <span class="st">"RELSER"</span>, <span class="st">"RELCTC35"</span><span class="op">)</span><span class="op">)</span>, auto_pre <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                                 A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                                                  (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE                122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of AEs                                              609           622            703      </span></span>
<span><span class="co">#&gt;   Total number of deaths                                       25 (18.7%)    23 (17.2%)      22 (16.7%)  </span></span>
<span><span class="co">#&gt;   Total number of patients withdrawn from study due to an AE    3 (2.2%)      6 (4.5%)        5 (3.8%)   </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one                                                             </span></span>
<span><span class="co">#&gt;     AE with fatal outcome                                      76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;     Serious AE                                                 104 (77.6%)   101 (75.4%)     99 (75.0%)  </span></span>
<span><span class="co">#&gt;     Related Serious AE                                         76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;     Related Grade 3-5                                          91 (67.9%)    90 (67.2%)      93 (70.5%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="safety-summary-adverse-events-of-special-interest-aet01_aesi">
<strong>Safety Summary (Adverse Events of Special Interest)
(<code>AET01_AESI</code>)</strong><a class="anchor" aria-label="anchor" href="#safety-summary-adverse-events-of-special-interest-aet01_aesi"></a>
</h3>
<div class="section level4">
<h4 id="safety-summary-adverse-events-of-special-interest">
<strong>1. Safety Summary (Adverse Events of Special
Interest)</strong><a class="anchor" aria-label="anchor" href="#safety-summary-adverse-events-of-special-interest"></a>
</h4>
<p>The <strong><code>aet01_aesi</code></strong> template produces the
standard safety summary for adverse events of special interest.</p>
<div class="sourceCode" id="cb3"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet01_aesi</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                                                    A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                                                                     (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE                                   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of AEs                                                                 609           622            703      </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE by worst grade                                                              </span></span>
<span><span class="co">#&gt;     Grade 1                                                                        7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;     Grade 2                                                                        6 (4.5%)      10 (7.5%)       7 (5.3%)   </span></span>
<span><span class="co">#&gt;     Grade 3                                                                       18 (13.4%)    14 (10.4%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;     Grade 4                                                                       15 (11.2%)    20 (14.9%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;     Grade 5 (fatal outcome)                                                       76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with study drug withdrawn due to AE                    27 (20.1%)    26 (19.4%)      30 (22.7%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with dose modified/interrupted due to AE               66 (49.3%)    76 (56.7%)      74 (56.1%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with treatment received for AE                         98 (73.1%)    102 (76.1%)    103 (78.0%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with all non-fatal AEs resolved                        84 (62.7%)    92 (68.7%)      97 (73.5%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one unresolved or ongoing non-fatal AE   102 (76.1%)   110 (82.1%)    107 (81.1%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one serious AE                           104 (77.6%)   101 (75.4%)     99 (75.0%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one related AE                           105 (78.4%)   108 (80.6%)    109 (82.6%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="safety-summary-adverse-events-of-special-interest-optional-lines">
<strong>2. Safety Summary (Adverse Events of Special Interest)
(optional lines)</strong><a class="anchor" aria-label="anchor" href="#safety-summary-adverse-events-of-special-interest-optional-lines"></a>
</h4>
<p>Additional analyses can be added with the parameter
<code>aesi_vars</code>, please type <code><a href="../reference/aet01_aesi.html">?aet01_aesi</a></code> in console
to find out the list of all pre-defined optional analyses in the
HELP.</p>
<div class="sourceCode" id="cb4"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet01_aesi</span>, <span class="va">syn_data</span>, aesi_vars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"RESLWD"</span>, <span class="st">"RELSER"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                                                    A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                                                                     (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE                                   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of AEs                                                                 609           622            703      </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE by worst grade                                                              </span></span>
<span><span class="co">#&gt;     Grade 1                                                                        7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;     Grade 2                                                                        6 (4.5%)      10 (7.5%)       7 (5.3%)   </span></span>
<span><span class="co">#&gt;     Grade 3                                                                       18 (13.4%)    14 (10.4%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;     Grade 4                                                                       15 (11.2%)    20 (14.9%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;     Grade 5 (fatal outcome)                                                       76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with study drug withdrawn due to AE                    27 (20.1%)    26 (19.4%)      30 (22.7%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with dose modified/interrupted due to AE               66 (49.3%)    76 (56.7%)      74 (56.1%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with treatment received for AE                         98 (73.1%)    102 (76.1%)    103 (78.0%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with all non-fatal AEs resolved                        84 (62.7%)    92 (68.7%)      97 (73.5%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one unresolved or ongoing non-fatal AE   102 (76.1%)   110 (82.1%)    107 (81.1%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one serious AE                           104 (77.6%)   101 (75.4%)     99 (75.0%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one related AE                           105 (78.4%)   108 (80.6%)    109 (82.6%)  </span></span>
<span><span class="co">#&gt;   No. of patients with serious, related AE                                        76 (56.7%)    70 (52.2%)      75 (56.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="safety-summary-adverse-events-of-special-interest-for-studies-with-multiple-drugs">
<strong>3. Safety Summary (Adverse Events of Special Interest) (for
studies with multiple drugs)</strong><a class="anchor" aria-label="anchor" href="#safety-summary-adverse-events-of-special-interest-for-studies-with-multiple-drugs"></a>
</h4>
<p>For studies with more than one study drug, users need to define the
analyses in <code>adae</code> and add to the parameter
<code>aesi_vars</code> following the example above. No pre-defined
analyses is available at this moment.</p>
</div>
</div>
<div class="section level3">
<h3 id="adverse-events-aet02">
<strong>Adverse Events (<code>AET02</code>)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-aet02"></a>
</h3>
<div class="section level4">
<h4 id="adverse-events">
<strong>1. Adverse Events</strong><a class="anchor" aria-label="anchor" href="#adverse-events"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The template <code>aet02</code> produces the standard adverse event
summary by MedDRA system organ class and preferred term.</li>
<li>The template does not include the column of total as default. The
‘All Patients’ column can be added by
<code>lbl_overall = "All Patients"</code>.</li>
<li>Missing values in <code>"AEBODSYS"</code>, and
<code>"AEDECOD"</code> are labeled by
<code>No Coding Available</code>.</li>
</ol>
<div class="sourceCode" id="cb5"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet02</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                     A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                                        (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one adverse event     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Overall total number of events                                   609           622            703      </span></span>
<span><span class="co">#&gt;   cl A.1                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         132           130            160      </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.1                                              50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl B.2                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         129           138            143      </span></span>
<span><span class="co">#&gt;     dcd B.2.2.3.1                                              48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.2.1.2.1                                              49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   cl D.1                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         127           106            135      </span></span>
<span><span class="co">#&gt;     dcd D.1.1.1.1                                              50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.4.2                                              48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl D.2                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         62            72              74      </span></span>
<span><span class="co">#&gt;     dcd D.2.1.5.3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;   cl B.1                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         56            60              62      </span></span>
<span><span class="co">#&gt;     dcd B.1.1.1.1                                              47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         48            53              65      </span></span>
<span><span class="co">#&gt;     dcd C.2.1.2.1                                              35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   cl C.1                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         55            63              64      </span></span>
<span><span class="co">#&gt;     dcd C.1.1.1.3                                              43 (32.1%)    46 (34.3%)      43 (32.6%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="adverse-events-with-high-level-term">
<strong>2. Adverse Events (with High-level Term)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-with-high-level-term"></a>
</h4>
<p>The syntax below displays adverse events by MedDRA system organ
class, high-level term and preferred term.</p>
<div class="sourceCode" id="cb6"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet02</span>, <span class="va">syn_data</span>, row_split_var <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AEBODSYS"</span>, <span class="st">"AEHLT"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                                                                  </span></span>
<span><span class="co">#&gt;     High Level Term                                                 A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;       MedDRA Preferred Term                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one adverse event         122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Overall total number of events                                       609           622            703      </span></span>
<span><span class="co">#&gt;   cl A.1                                                                                                     </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event       78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                             132           130            160      </span></span>
<span><span class="co">#&gt;       hlt A.1.1.1                                                                                            </span></span>
<span><span class="co">#&gt;         Total number of patients with at least one adverse event   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;         Total number of events                                         132           130            160      </span></span>
<span><span class="co">#&gt;         dcd A.1.1.1.1                                              50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;         dcd A.1.1.1.2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl B.2                                                                                                     </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event       79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                             129           138            143      </span></span>
<span><span class="co">#&gt;       hlt B.2.2.3                                                                                            </span></span>
<span><span class="co">#&gt;         Total number of patients with at least one adverse event   48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;         Total number of events                                         64            76              77      </span></span>
<span><span class="co">#&gt;         dcd B.2.2.3.1                                              48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;       hlt B.2.1.2                                                                                            </span></span>
<span><span class="co">#&gt;         Total number of patients with at least one adverse event   49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;         Total number of events                                         65            62              66      </span></span>
<span><span class="co">#&gt;         dcd B.2.1.2.1                                              49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   cl D.1                                                                                                     </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event       79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                             127           106            135      </span></span>
<span><span class="co">#&gt;       hlt D.1.1.1                                                                                            </span></span>
<span><span class="co">#&gt;         Total number of patients with at least one adverse event   50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;         Total number of events                                         61            51              71      </span></span>
<span><span class="co">#&gt;         dcd D.1.1.1.1                                              50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;       hlt D.1.1.4                                                                                            </span></span>
<span><span class="co">#&gt;         Total number of patients with at least one adverse event   48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;         Total number of events                                         66            55              64      </span></span>
<span><span class="co">#&gt;         dcd D.1.1.4.2                                              48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl D.2                                                                                                     </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                             62            72              74      </span></span>
<span><span class="co">#&gt;       hlt D.2.1.5                                                                                            </span></span>
<span><span class="co">#&gt;         Total number of patients with at least one adverse event   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;         Total number of events                                         62            72              74      </span></span>
<span><span class="co">#&gt;         dcd D.2.1.5.3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;   cl B.1                                                                                                     </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event       47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                             56            60              62      </span></span>
<span><span class="co">#&gt;       hlt B.1.1.1                                                                                            </span></span>
<span><span class="co">#&gt;         Total number of patients with at least one adverse event   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;         Total number of events                                         56            60              62      </span></span>
<span><span class="co">#&gt;         dcd B.1.1.1.1                                              47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                                                     </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                             48            53              65      </span></span>
<span><span class="co">#&gt;       hlt C.2.1.2                                                                                            </span></span>
<span><span class="co">#&gt;         Total number of patients with at least one adverse event   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;         Total number of events                                         48            53              65      </span></span>
<span><span class="co">#&gt;         dcd C.2.1.2.1                                              35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   cl C.1                                                                                                     </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                             55            63              64      </span></span>
<span><span class="co">#&gt;       hlt C.1.1.1                                                                                            </span></span>
<span><span class="co">#&gt;         Total number of patients with at least one adverse event   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;         Total number of events                                         55            63              64      </span></span>
<span><span class="co">#&gt;         dcd C.1.1.1.3                                              43 (32.1%)    46 (34.3%)      43 (32.6%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="adverse-events-preferred-terms-only">
<strong>3. Adverse Events (Preferred Terms only)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-preferred-terms-only"></a>
</h4>
<p>The syntax below displays adverse events by preferred term only.</p>
<div class="sourceCode" id="cb7"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet02</span>, <span class="va">syn_data</span>, row_split_var <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA Preferred Term                                       A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                                                (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one adverse event   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Overall total number of events                                 609           622            703      </span></span>
<span><span class="co">#&gt;   dcd D.2.1.5.3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.1                                              50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.2.3.1                                              48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.1.2.1                                              49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.1.1                                              50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.4.2                                              48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.1.1.1.1                                              47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   dcd C.2.1.2.1                                              35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   dcd C.1.1.1.3                                              43 (32.1%)    46 (34.3%)      43 (32.6%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="adverse-events-by-greatest-intensityaet03">
<strong>Adverse Events by Greatest
Intensity(<code>AET03</code>)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-greatest-intensityaet03"></a>
</h3>
<div class="section level4">
<h4 id="adverse-events-by-greatest-intensity">
<strong>1. Adverse Events by Greatest Intensity</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-greatest-intensity"></a>
</h4>
<p>This <strong><code>aet03</code></strong> template produces the
standard adverse event by greatest intensity summary</p>
<div class="sourceCode" id="cb8"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet03</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class    A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term       (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   - Any Intensity -           122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   MILD                         7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;   MODERATE                    24 (17.9%)    24 (17.9%)      23 (17.4%)  </span></span>
<span><span class="co">#&gt;   SEVERE                      91 (67.9%)    90 (67.2%)      93 (70.5%)  </span></span>
<span><span class="co">#&gt;   cl A.1                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     MILD                      30 (22.4%)    27 (20.1%)      39 (29.5%)  </span></span>
<span><span class="co">#&gt;     MODERATE                  48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;       MILD                    50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.2                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;       MODERATE                48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl B.2                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;     MILD                      30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;     MODERATE                  49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;     dcd B.2.2.3.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;       MILD                    48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.2.1.2.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;       MODERATE                49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   cl D.1                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;     MODERATE                  29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;     SEVERE                    50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.1.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;       SEVERE                  50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.4.2                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;       MODERATE                48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl D.2                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     MILD                      47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     dcd D.2.1.5.3                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;       MILD                    47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;   cl B.1                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     SEVERE                    47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.1.1.1.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;       SEVERE                  47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     MODERATE                  35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     dcd C.2.1.2.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;       MODERATE                35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   cl C.1                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     SEVERE                    43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd C.1.1.1.3                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;       SEVERE                  43 (32.1%)    46 (34.3%)      43 (32.6%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="adverse-events-by-highest-nci-ctcae-grade-aet04">
<strong>Adverse Events by Highest <code>NCI CTCAE</code> Grade
(<code>AET04</code>)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-highest-nci-ctcae-grade-aet04"></a>
</h3>
<div class="section level4">
<h4 id="adverse-events-by-highest-nci-ctcae-grade">
<strong>1. Adverse Events by Highest <code>NCI CTCAE</code>
Grade</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-highest-nci-ctcae-grade"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>aet04</code></strong> template produces the
standard adverse event by highest <code>NCI CTCAE</code> grade
summary.<br>
</li>
<li>By default, this template includes the grouped grades of ‘Grade 1-2’
and ‘Grade 3-4’.<br>
</li>
<li>By default this template removes the rows with 0 count.<br>
</li>
<li>If a treatment group does not have any adverse event, the treatment
group is automatically displayed providing that it is defined in
<code>ADSL</code>.</li>
</ol>
<div class="sourceCode" id="cb9"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet04</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                                             </span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                      A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                               Grade             (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   - Any adverse events -                                                                </span></span>
<span><span class="co">#&gt;                               - Any Grade -   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2        13 (9.7%)    19 (14.2%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;                               1                7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;                               2                6 (4.5%)      10 (7.5%)       7 (5.3%)   </span></span>
<span><span class="co">#&gt;                               Grade 3-4       33 (24.6%)    34 (25.4%)      34 (25.8%)  </span></span>
<span><span class="co">#&gt;                               3               18 (13.4%)    14 (10.4%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                               4               15 (11.2%)    20 (14.9%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;   cl A.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    27 (20.1%)      39 (29.5%)  </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               1               50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl B.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;     dcd B.2.2.3.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               1               48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   cl D.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;                               3               29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.4.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               3               48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl D.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     dcd D.2.1.5.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;   cl B.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     dcd C.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   cl C.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd C.1.1.1.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="adverse-events-by-highest-nci-ctcae-grade-fill-in-of-grades">
<strong>2. Adverse Events by Highest <code>NCI CTCAE</code> Grade
(Fill in of Grades)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-highest-nci-ctcae-grade-fill-in-of-grades"></a>
</h4>
<p>If for some preferred terms not all grades occur but all grades
should be displayed, this can be achieved by specifying
<code>prune_0 = FALSE</code>.</p>
<div class="sourceCode" id="cb10"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet04</span>, <span class="va">syn_data</span>, prune_0 <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                                             </span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                      A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                               Grade             (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   - Any adverse events -                                                                </span></span>
<span><span class="co">#&gt;                               - Any Grade -   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2        13 (9.7%)    19 (14.2%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;                               1                7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;                               2                6 (4.5%)      10 (7.5%)       7 (5.3%)   </span></span>
<span><span class="co">#&gt;                               Grade 3-4       33 (24.6%)    34 (25.4%)      34 (25.8%)  </span></span>
<span><span class="co">#&gt;                               3               18 (13.4%)    14 (10.4%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                               4               15 (11.2%)    20 (14.9%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;   cl A.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    27 (20.1%)      39 (29.5%)  </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               1               50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;   cl B.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd B.2.2.3.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               1               48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd B.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;   cl D.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;                               3               29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5         50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5         50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.4.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               3               48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;   cl D.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd D.2.1.5.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;   cl B.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5         47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5         47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd C.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;   cl C.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd C.1.1.1.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="adverse-events-by-highest-nci-ctcae-grade-with-modified-grouping-of-grade">
<strong>3. Adverse Events by Highest <code>NCI CTCAE</code> Grade
with modified grouping of grade</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-highest-nci-ctcae-grade-with-modified-grouping-of-grade"></a>
</h4>
<p>To collapse grade 3-4 with grade 5, this can be achieved by modifying
the definition of grade groups in <code>grade_groups</code>.</p>
<div class="sourceCode" id="cb11"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">grade_groups</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span></span>
<span>  <span class="st">"Grade 1-2"</span> <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"1"</span>, <span class="st">"2"</span><span class="op">)</span>,</span>
<span>  <span class="st">"Grade 3-5"</span> <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"3"</span>, <span class="st">"4"</span>, <span class="st">"5"</span><span class="op">)</span></span>
<span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet04</span>, <span class="va">syn_data</span>, grade_groups <span class="op">=</span> <span class="va">grade_groups</span>, prune_0 <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                                             </span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                      A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                               Grade             (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   - Any adverse events -                                                                </span></span>
<span><span class="co">#&gt;                               - Any Grade -   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2        13 (9.7%)    19 (14.2%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;                               1                7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;                               2                6 (4.5%)      10 (7.5%)       7 (5.3%)   </span></span>
<span><span class="co">#&gt;                               Grade 3-5       109 (81.3%)   104 (77.6%)    109 (82.6%)  </span></span>
<span><span class="co">#&gt;                               3               18 (13.4%)    14 (10.4%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                               4               15 (11.2%)    20 (14.9%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;                               5               76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;   cl A.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    27 (20.1%)      39 (29.5%)  </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               1               50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;   cl B.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd B.2.2.3.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               1               48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd B.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;   cl D.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;                               3               29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5               50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5               50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.4.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               3               48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;   cl D.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd D.2.1.5.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;   cl B.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5               47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5               47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd C.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;   cl C.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd C.1.1.1.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               5                    0             0              0</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="most-common-5-adverse-events-aet05">
<strong>Most Common (&gt;=5%) Adverse Events
(<code>AET05</code>)</strong><a class="anchor" aria-label="anchor" href="#most-common-5-adverse-events-aet05"></a>
</h3>
<div class="section level4">
<h4 id="most-common-5-adverse-events">
<strong>1. Most Common (&gt;=5%) Adverse Events</strong><a class="anchor" aria-label="anchor" href="#most-common-5-adverse-events"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>aet10</code></strong> template produces the
standard most common adverse events occurring with relative frequency
&gt;=5% output.</li>
</ol>
<div class="sourceCode" id="cb12"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet10</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                           A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;   MedDRA Preferred Term    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   dcd D.2.1.5.3           47 (35.1%)   58 (43.3%)     57 (43.2%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.1           50 (37.3%)   45 (33.6%)     63 (47.7%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.2.3.1           48 (35.8%)   54 (40.3%)     51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.2           48 (35.8%)   48 (35.8%)     50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.1.2.1           49 (36.6%)   44 (32.8%)     52 (39.4%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.1.1           50 (37.3%)   42 (31.3%)     51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.4.2           48 (35.8%)   42 (31.3%)     50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.1.1.1.1           47 (35.1%)   49 (36.6%)     43 (32.6%)  </span></span>
<span><span class="co">#&gt;   dcd C.2.1.2.1           35 (26.1%)   48 (35.8%)     55 (41.7%)  </span></span>
<span><span class="co">#&gt;   dcd C.1.1.1.3           43 (32.1%)   46 (34.3%)     43 (32.6%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="most-common-8-adverse-events-setting-threshold">
<strong>2. Most Common (&gt;=8%) Adverse Events (setting
threshold)</strong><a class="anchor" aria-label="anchor" href="#most-common-8-adverse-events-setting-threshold"></a>
</h4>
<p>To modify the threshold for displaying preferred terms, this can be
achieved by providing the threshold to the <code>atleast</code>
parameter.</p>
<div class="sourceCode" id="cb13"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet10</span>, <span class="va">syn_data</span>, atleast <span class="op">=</span> <span class="fl">0.08</span><span class="op">)</span></span>
<span><span class="co">#&gt;                           A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;   MedDRA Preferred Term    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   dcd D.2.1.5.3           47 (35.1%)   58 (43.3%)     57 (43.2%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.1           50 (37.3%)   45 (33.6%)     63 (47.7%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.2.3.1           48 (35.8%)   54 (40.3%)     51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.2           48 (35.8%)   48 (35.8%)     50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.1.2.1           49 (36.6%)   44 (32.8%)     52 (39.4%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.1.1           50 (37.3%)   42 (31.3%)     51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.4.2           48 (35.8%)   42 (31.3%)     50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.1.1.1.1           47 (35.1%)   49 (36.6%)     43 (32.6%)  </span></span>
<span><span class="co">#&gt;   dcd C.2.1.2.1           35 (26.1%)   48 (35.8%)     55 (41.7%)  </span></span>
<span><span class="co">#&gt;   dcd C.1.1.1.3           43 (32.1%)   46 (34.3%)     43 (32.6%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="concomitant-medications-by-medication-class-and-preferred-name-cmt01a">
<strong>Concomitant Medications by Medication Class and Preferred
Name (<code>CMT01A</code>)</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-medication-class-and-preferred-name-cmt01a"></a>
</h3>
<div class="section level4">
<h4 id="concomitant-medications-by-medication-class-and-preferred-name">
<strong>1. Concomitant Medications by Medication Class and Preferred
Name</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-medication-class-and-preferred-name"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>cmt01a</code></strong> template displays
concomitant medications by <code>ATC Level 2</code> and Preferred Name
by default.<br>
</li>
<li>The template does not include the column of total by default.<br>
</li>
<li>The template sort medication class and preferred name by
alphabetical order by default.</li>
</ol>
<div class="sourceCode" id="cb14"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">cmt01a</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   ATC Level 2 Text                                          A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     Other Treatment                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one treatment     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of treatments                                   609           622            703      </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   97 (72.4%)    98 (73.1%)     102 (77.3%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 205           207            242      </span></span>
<span><span class="co">#&gt;     medname A_1/3                                          54 (40.3%)    49 (36.6%)      69 (52.3%)  </span></span>
<span><span class="co">#&gt;     medname A_2/3                                          53 (39.6%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 58            66              64      </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   102 (76.1%)   101 (75.4%)    108 (81.8%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 264           275            306      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname B_4/4                                          50 (37.3%)    45 (33.6%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     medname B_3/4                                          47 (35.1%)    47 (35.1%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 69            73              80      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="concomitant-medications-by-medication-class-and-preferred-name-changing-atc-class-level">
<strong>2. Concomitant Medications by Medication Class and Preferred
Name (changing <code>ATC class level</code>)</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-medication-class-and-preferred-name-changing-atc-class-level"></a>
</h4>
<div class="sourceCode" id="cb15"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">cmt01a</span>, <span class="va">syn_data</span>, row_split_var <span class="op">=</span> <span class="st">"ATC1"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   ATC Level 1 Text                                          A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     Other Treatment                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one treatment     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of treatments                                   609           622            703      </span></span>
<span><span class="co">#&gt;   ATCCLAS1 A                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   97 (72.4%)    98 (73.1%)     102 (77.3%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 205           207            242      </span></span>
<span><span class="co">#&gt;     medname A_1/3                                          54 (40.3%)    49 (36.6%)      69 (52.3%)  </span></span>
<span><span class="co">#&gt;     medname A_2/3                                          53 (39.6%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 A p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 58            66              64      </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 B                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   102 (76.1%)   101 (75.4%)    108 (81.8%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 264           275            306      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname B_4/4                                          50 (37.3%)    45 (33.6%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     medname B_3/4                                          47 (35.1%)    47 (35.1%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 B p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 B p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 C                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 C p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 C p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 69            73              80      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="concomitant-medications-by-medication-class-and-preferred-name-classes-sorted-by-frequency">
<strong>3. Concomitant Medications by Medication Class and Preferred
Name (classes sorted by frequency)</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-medication-class-and-preferred-name-classes-sorted-by-frequency"></a>
</h4>
<p>The option <code>sort_by_freq = TRUE</code> sort medication class by
frequency.</p>
<div class="sourceCode" id="cb16"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">cmt01a</span>, <span class="va">syn_data</span>, sort_by_freq <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt;   ATC Level 2 Text                                          A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     Other Treatment                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one treatment     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of treatments                                   609           622            703      </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   102 (76.1%)   101 (75.4%)    108 (81.8%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 264           275            306      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname B_4/4                                          50 (37.3%)    45 (33.6%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     medname B_3/4                                          47 (35.1%)    47 (35.1%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   97 (72.4%)    98 (73.1%)     102 (77.3%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 205           207            242      </span></span>
<span><span class="co">#&gt;     medname A_1/3                                          54 (40.3%)    49 (36.6%)      69 (52.3%)  </span></span>
<span><span class="co">#&gt;     medname A_2/3                                          53 (39.6%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 69            73              80      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 58            66              64      </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="concomitant-medications-by-medication-class-and-preferred-name-total-number-of-treatments-per-medication-class-suppressed">
<strong>4. Concomitant Medications by Medication Class and Preferred
Name (total number of treatments per medication class
suppressed)</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-medication-class-and-preferred-name-total-number-of-treatments-per-medication-class-suppressed"></a>
</h4>
<p>The <strong><code>cmt01a</code></strong> template includes the
analysis of ‘total number of treatments’ by default, use
<code>incl_n_treatment = FALSE</code> to remove it.</p>
<div class="sourceCode" id="cb17"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">cmt01a</span>, <span class="va">syn_data</span>, incl_n_treatment <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;   ATC Level 2 Text                                          A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     Other Treatment                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one treatment     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of treatments                                   609           622            703      </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   97 (72.4%)    98 (73.1%)     102 (77.3%)  </span></span>
<span><span class="co">#&gt;     medname A_1/3                                          54 (40.3%)    49 (36.6%)      69 (52.3%)  </span></span>
<span><span class="co">#&gt;     medname A_2/3                                          53 (39.6%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   102 (76.1%)   101 (75.4%)    108 (81.8%)  </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname B_4/4                                          50 (37.3%)    45 (33.6%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     medname B_3/4                                          47 (35.1%)    47 (35.1%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="concomitant-medications-by-preferred-name-cmt02_pt">
<strong>Concomitant Medications by Preferred Name
(<code>CMT02_PT</code>)</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-preferred-name-cmt02_pt"></a>
</h3>
<div class="section level4">
<h4 id="concomitant-medications-by-preferred-name">
<strong>1. Concomitant Medications by Preferred Name</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-preferred-name"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>cmt02_pt</code></strong> template displays
concomitant medications by Preferred Name by default.<br>
</li>
<li>The template does not include the column of total by default.<br>
</li>
<li>The template sorts preferred name by alphabetical order by default.
Set the option <code>sort_by_freq = TRUE</code> to sort preferred names
by frequency.</li>
</ol>
<div class="sourceCode" id="cb18"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">cmt02_pt</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Other Treatment                                         A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                                            (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one treatment   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of treatments                                 609           622            703      </span></span>
<span><span class="co">#&gt;   medname A_1/3                                          54 (40.3%)    49 (36.6%)      69 (52.3%)  </span></span>
<span><span class="co">#&gt;   medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;   medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;   medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   medname A_2/3                                          53 (39.6%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   medname B_4/4                                          50 (37.3%)    45 (33.6%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   medname B_3/4                                          47 (35.1%)    47 (35.1%)      52 (39.4%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="demographics-and-baseline-characteristics-dmt01">
<strong>Demographics and Baseline Characteristics
(<code>DMT01</code>)</strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-dmt01"></a>
</h3>
<div class="section level4">
<h4 id="demographics-and-baseline-characteristics-with-all-patients">
<strong>1. Demographics and Baseline Characteristics with All
Patients</strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-with-all-patients"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>dmt01</code></strong> template produces the
standard demographics and baseline characteristics summary.<br>
</li>
<li>This template includes the column of total by default.</li>
</ol>
<div class="sourceCode" id="cb19"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         A: Drug X    B: Placebo    C: Combination   All Patients</span></span>
<span><span class="co">#&gt;                                          (N=134)       (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age (yr)                                                                                      </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Mean (SD)                          33.8 (6.6)    35.4 (7.9)      35.4 (7.7)      34.9 (7.4) </span></span>
<span><span class="co">#&gt;     Median                                33.0          35.0            35.0            34.0    </span></span>
<span><span class="co">#&gt;     Min - Max                          21.0 - 50.0   21.0 - 62.0    20.0 - 69.0     20.0 - 69.0 </span></span>
<span><span class="co">#&gt;   Age Group                                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     &lt;65                                134 (100%)    134 (100%)     131 (99.2%)     399 (99.8%) </span></span>
<span><span class="co">#&gt;     &gt;=65                                    0             0           1 (0.8%)        1 (0.2%)  </span></span>
<span><span class="co">#&gt;   Sex                                                                                           </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Male                               55 (41.0%)    52 (38.8%)      62 (47.0%)     169 (42.2%) </span></span>
<span><span class="co">#&gt;     Female                             79 (59.0%)    82 (61.2%)      70 (53.0%)     231 (57.8%) </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     NOT REPORTED                        6 (4.5%)      10 (7.5%)      11 (8.3%)       27 (6.8%)  </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                 15 (11.2%)    18 (13.4%)      15 (11.4%)      48 (12.0%) </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO             104 (77.6%)   103 (76.9%)    101 (76.5%)     308 (77.0%) </span></span>
<span><span class="co">#&gt;     UNKNOWN                             9 (6.7%)      3 (2.2%)        5 (3.8%)       17 (4.2%)  </span></span>
<span><span class="co">#&gt;   RACE                                                                                          </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE    8 (6.0%)      11 (8.2%)       6 (4.5%)       25 (6.2%)  </span></span>
<span><span class="co">#&gt;     ASIAN                              68 (50.7%)    68 (50.7%)      73 (55.3%)     209 (52.2%) </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN          31 (23.1%)    28 (20.9%)      32 (24.2%)      91 (22.8%) </span></span>
<span><span class="co">#&gt;     WHITE                              27 (20.1%)    27 (20.1%)      21 (15.9%)      75 (18.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="demographics-and-baseline-characteristics-without-all-patients">
<strong>2. Demographics and Baseline Characteristics without All
Patients</strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-without-all-patients"></a>
</h4>
<p>To remove the column of total, set the parameter
<code>lbl_overall</code> to <code>NULL</code>.</p>
<div class="sourceCode" id="cb20"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">syn_data</span>, lbl_overall <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age (yr)                                                                       </span></span>
<span><span class="co">#&gt;     n                                      134           134            132      </span></span>
<span><span class="co">#&gt;     Mean (SD)                          33.8 (6.6)    35.4 (7.9)      35.4 (7.7)  </span></span>
<span><span class="co">#&gt;     Median                                33.0          35.0            35.0     </span></span>
<span><span class="co">#&gt;     Min - Max                          21.0 - 50.0   21.0 - 62.0    20.0 - 69.0  </span></span>
<span><span class="co">#&gt;   Age Group                                                                      </span></span>
<span><span class="co">#&gt;     n                                      134           134            132      </span></span>
<span><span class="co">#&gt;     &lt;65                                134 (100%)    134 (100%)     131 (99.2%)  </span></span>
<span><span class="co">#&gt;     &gt;=65                                    0             0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;   Sex                                                                            </span></span>
<span><span class="co">#&gt;     n                                      134           134            132      </span></span>
<span><span class="co">#&gt;     Male                               55 (41.0%)    52 (38.8%)      62 (47.0%)  </span></span>
<span><span class="co">#&gt;     Female                             79 (59.0%)    82 (61.2%)      70 (53.0%)  </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                      </span></span>
<span><span class="co">#&gt;     n                                      134           134            132      </span></span>
<span><span class="co">#&gt;     NOT REPORTED                        6 (4.5%)      10 (7.5%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                 15 (11.2%)    18 (13.4%)      15 (11.4%)  </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO             104 (77.6%)   103 (76.9%)    101 (76.5%)  </span></span>
<span><span class="co">#&gt;     UNKNOWN                             9 (6.7%)      3 (2.2%)        5 (3.8%)   </span></span>
<span><span class="co">#&gt;   RACE                                                                           </span></span>
<span><span class="co">#&gt;     n                                      134           134            132      </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE    8 (6.0%)      11 (8.2%)       6 (4.5%)   </span></span>
<span><span class="co">#&gt;     ASIAN                              68 (50.7%)    68 (50.7%)      73 (55.3%)  </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN          31 (23.1%)    28 (20.9%)      32 (24.2%)  </span></span>
<span><span class="co">#&gt;     WHITE                              27 (20.1%)    27 (20.1%)      21 (15.9%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="demographics-and-baseline-characteristics-with-an-additional-study-specific-continuous-variable">
<strong>3. Demographics and Baseline Characteristics with an
additional study specific continuous variable</strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-with-an-additional-study-specific-continuous-variable"></a>
</h4>
<ol style="list-style-type: decimal">
<li>Study specific continuous variables can be added to the standard
demographics and baseline characteristics summary by editing the
parameter <code>summaryvars</code>. To add or remove analyses, you need
to list all variables you would like to include in the parameter.<br>
</li>
<li>CHEVRON performs the analysis based on the type of variable as
defined in the input data.</li>
</ol>
<div class="sourceCode" id="cb21"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">syn_data</span>, summaryvars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AGE"</span>, <span class="st">"AGEGR1"</span>, <span class="st">"SEX"</span>, <span class="st">"ETHNIC"</span>, <span class="st">"RACE"</span>, <span class="st">"BBMISI"</span><span class="op">)</span>, lbl_overall <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         A: Drug X     B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;                                          (N=134)        (N=134)         (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age                                                                              </span></span>
<span><span class="co">#&gt;     n                                      134            134             132      </span></span>
<span><span class="co">#&gt;     Mean (SD)                          33.8 (6.6)     35.4 (7.9)       35.4 (7.7)  </span></span>
<span><span class="co">#&gt;     Median                                33.0           35.0             35.0     </span></span>
<span><span class="co">#&gt;     Min - Max                          21.0 - 50.0    21.0 - 62.0     20.0 - 69.0  </span></span>
<span><span class="co">#&gt;   Age Group                                                                        </span></span>
<span><span class="co">#&gt;     n                                      134            134             132      </span></span>
<span><span class="co">#&gt;     &lt;65                                134 (100%)     134 (100%)      131 (99.2%)  </span></span>
<span><span class="co">#&gt;     &gt;=65                                    0              0            1 (0.8%)   </span></span>
<span><span class="co">#&gt;   Sex                                                                              </span></span>
<span><span class="co">#&gt;     n                                      134            134             132      </span></span>
<span><span class="co">#&gt;     Male                               55 (41.0%)     52 (38.8%)       62 (47.0%)  </span></span>
<span><span class="co">#&gt;     Female                             79 (59.0%)     82 (61.2%)       70 (53.0%)  </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                        </span></span>
<span><span class="co">#&gt;     n                                      134            134             132      </span></span>
<span><span class="co">#&gt;     NOT REPORTED                        6 (4.5%)       10 (7.5%)       11 (8.3%)   </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                 15 (11.2%)     18 (13.4%)       15 (11.4%)  </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO             104 (77.6%)    103 (76.9%)     101 (76.5%)  </span></span>
<span><span class="co">#&gt;     UNKNOWN                             9 (6.7%)       3 (2.2%)         5 (3.8%)   </span></span>
<span><span class="co">#&gt;   RACE                                                                             </span></span>
<span><span class="co">#&gt;     n                                      134            134             132      </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE    8 (6.0%)       11 (8.2%)        6 (4.5%)   </span></span>
<span><span class="co">#&gt;     ASIAN                              68 (50.7%)     68 (50.7%)       73 (55.3%)  </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN          31 (23.1%)     28 (20.9%)       32 (24.2%)  </span></span>
<span><span class="co">#&gt;     WHITE                              27 (20.1%)     27 (20.1%)       21 (15.9%)  </span></span>
<span><span class="co">#&gt;   Baseline BMI                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134            134             132      </span></span>
<span><span class="co">#&gt;     Mean (SD)                          30.0 (18.3)    32.4 (23.2)     30.1 (18.4)  </span></span>
<span><span class="co">#&gt;     Median                                27.1           31.1             30.0     </span></span>
<span><span class="co">#&gt;     Min - Max                          -6.9 - 75.9   -26.6 - 117.9    -44.2 - 87.5</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="demographics-and-baseline-characteristics-with-an-additional-study-specific-categorical-variable">
<strong>4. Demographics and Baseline Characteristics with an
additional study specific categorical variable</strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-with-an-additional-study-specific-categorical-variable"></a>
</h4>
<ol style="list-style-type: decimal">
<li>Study specific categorical variables can be added to the standard
demographics and baseline characteristics summary by editing the
parameter <code>summaryvars</code>.<br>
</li>
<li>To display the values within a categorical variable in pre-specified
order, the categorical variable need to be factorized with pre-specified
order provided as levels.</li>
</ol>
<div class="sourceCode" id="cb22"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="va">syn_data</span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span></span>
<span>    SEX <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/reformat.html" class="external-link">reformat</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">SEX</span>, <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/rule.html" class="external-link">rule</a></span><span class="op">(</span>Male <span class="op">=</span> <span class="st">"M"</span>, Female <span class="op">=</span> <span class="st">"F"</span><span class="op">)</span><span class="op">)</span>,</span>
<span>    BBMIGR1 <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/factor.html" class="external-link">factor</a></span><span class="op">(</span><span class="fu"><a href="https://dplyr.tidyverse.org/reference/case_when.html" class="external-link">case_when</a></span><span class="op">(</span></span>
<span>      <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">15</span> <span class="op">~</span> <span class="st">"Very severely underweight"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">15</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">16</span> <span class="op">~</span> <span class="st">"Severely underweight"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">16</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">18.5</span> <span class="op">~</span> <span class="st">"Underweight"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">18.5</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">25</span> <span class="op">~</span> <span class="st">"Normal (healthy weight)"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">25</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">30</span> <span class="op">~</span> <span class="st">"Overweight"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">30</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">35</span> <span class="op">~</span> <span class="st">"Obese Class I (Moderately obese)"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">35</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">40</span> <span class="op">~</span> <span class="st">"Obese Class II (Severely obese)"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">40</span> <span class="op">~</span> <span class="st">"Obese Class III (Very severely obese)"</span></span>
<span>    <span class="op">)</span>, levels <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span></span>
<span>      <span class="st">"Very severely underweight"</span>,</span>
<span>      <span class="st">"Severely underweight"</span>,</span>
<span>      <span class="st">"Underweight"</span>,</span>
<span>      <span class="st">"Normal (healthy weight)"</span>,</span>
<span>      <span class="st">"Overweight"</span>,</span>
<span>      <span class="st">"Obese Class I (Moderately obese)"</span>,</span>
<span>      <span class="st">"Obese Class II (Severely obese)"</span>,</span>
<span>      <span class="st">"Obese Class III (Very severely obese)"</span></span>
<span>    <span class="op">)</span><span class="op">)</span></span>
<span>  <span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">proc_data</span>, summaryvars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AGE"</span>, <span class="st">"AGEGR1"</span>, <span class="st">"SEX"</span>, <span class="st">"ETHNIC"</span>, <span class="st">"RACE"</span>, <span class="st">"BBMIGR1"</span><span class="op">)</span>, auto_pre <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                              A: Drug X    B: Placebo    C: Combination   All Patients</span></span>
<span><span class="co">#&gt;                                               (N=134)       (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age                                                                                                </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     Mean (SD)                               33.8 (6.6)    35.4 (7.9)      35.4 (7.7)      34.9 (7.4) </span></span>
<span><span class="co">#&gt;     Median                                     33.0          35.0            35.0            34.0    </span></span>
<span><span class="co">#&gt;     Min - Max                               21.0 - 50.0   21.0 - 62.0    20.0 - 69.0     20.0 - 69.0 </span></span>
<span><span class="co">#&gt;   Age Group                                                                                          </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     &lt;65                                     134 (100%)    134 (100%)     131 (99.2%)     399 (99.8%) </span></span>
<span><span class="co">#&gt;     &gt;=65                                         0             0           1 (0.8%)        1 (0.2%)  </span></span>
<span><span class="co">#&gt;   Sex                                                                                                </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     Male                                    55 (41.0%)    52 (38.8%)      62 (47.0%)     169 (42.2%) </span></span>
<span><span class="co">#&gt;     Female                                  79 (59.0%)    82 (61.2%)      70 (53.0%)     231 (57.8%) </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                                          </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     NOT REPORTED                             6 (4.5%)      10 (7.5%)      11 (8.3%)       27 (6.8%)  </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                      15 (11.2%)    18 (13.4%)      15 (11.4%)      48 (12.0%) </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO                  104 (77.6%)   103 (76.9%)    101 (76.5%)     308 (77.0%) </span></span>
<span><span class="co">#&gt;     UNKNOWN                                  9 (6.7%)      3 (2.2%)        5 (3.8%)       17 (4.2%)  </span></span>
<span><span class="co">#&gt;   RACE                                                                                               </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE         8 (6.0%)      11 (8.2%)       6 (4.5%)       25 (6.2%)  </span></span>
<span><span class="co">#&gt;     ASIAN                                   68 (50.7%)    68 (50.7%)      73 (55.3%)     209 (52.2%) </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN               31 (23.1%)    28 (20.9%)      32 (24.2%)      91 (22.8%) </span></span>
<span><span class="co">#&gt;     WHITE                                   27 (20.1%)    27 (20.1%)      21 (15.9%)      75 (18.8%) </span></span>
<span><span class="co">#&gt;   BBMIGR1                                                                                            </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     Very severely underweight               31 (23.1%)    29 (21.6%)      24 (18.2%)      84 (21.0%) </span></span>
<span><span class="co">#&gt;     Severely underweight                     4 (3.0%)      1 (0.7%)        1 (0.8%)        6 (1.5%)  </span></span>
<span><span class="co">#&gt;     Underweight                              9 (6.7%)      7 (5.2%)        3 (2.3%)       19 (4.8%)  </span></span>
<span><span class="co">#&gt;     Normal (healthy weight)                 17 (12.7%)    18 (13.4%)      20 (15.2%)      55 (13.8%) </span></span>
<span><span class="co">#&gt;     Overweight                               11 (8.2%)     10 (7.5%)      18 (13.6%)      39 (9.8%)  </span></span>
<span><span class="co">#&gt;     Obese Class I (Moderately obese)         12 (9.0%)     11 (8.2%)      16 (12.1%)      39 (9.8%)  </span></span>
<span><span class="co">#&gt;     Obese Class II (Severely obese)          11 (8.2%)     13 (9.7%)      16 (12.1%)      40 (10.0%) </span></span>
<span><span class="co">#&gt;     Obese Class III (Very severely obese)   39 (29.1%)    45 (33.6%)      34 (25.8%)     118 (29.5%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="demographics-and-baseline-characteristics-with-additional-vital-signs-baseline-values-from-advs-or-adsub">
<strong>5. Demographics and Baseline Characteristics with additional
vital signs baseline values from <code>ADVS</code> or
<code>ADSUB</code></strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-with-additional-vital-signs-baseline-values-from-advs-or-adsub"></a>
</h4>
<p>To add baseline vital signs or other baseline characteristics to the
demographics and baseline characteristics summary, manual preprocess of
input <code>adsl</code> dataset is expected and merge the vital signs
baseline values from <code>advs</code> (where
<code>ADVS.ABLFL == "Y"</code>) or <code>adsub</code> with
<code>adsl</code> by unique subject identifier.</p>
<div class="sourceCode" id="cb23"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="va">syn_data</span></span>
<span><span class="va">diabpbl</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">advs</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/filter.html" class="external-link">filter</a></span><span class="op">(</span><span class="va">ABLFL</span> <span class="op">==</span> <span class="st">"Y"</span> <span class="op">&amp;</span> <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"DIABP"</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span>DIABPBL <span class="op">=</span> <span class="va">AVAL</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/select.html" class="external-link">select</a></span><span class="op">(</span><span class="st">"STUDYID"</span>, <span class="st">"USUBJID"</span>, <span class="st">"DIABPBL"</span><span class="op">)</span></span>
<span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span>SEX <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/reformat.html" class="external-link">reformat</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">SEX</span>, <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/rule.html" class="external-link">rule</a></span><span class="op">(</span>Male <span class="op">=</span> <span class="st">"M"</span>, Female <span class="op">=</span> <span class="st">"F"</span><span class="op">)</span><span class="op">)</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate-joins.html" class="external-link">left_join</a></span><span class="op">(</span><span class="va">diabpbl</span>, by <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"STUDYID"</span>, <span class="st">"USUBJID"</span><span class="op">)</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">proc_data</span>, summaryvars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AGE"</span>, <span class="st">"AGEGR1"</span>, <span class="st">"SEX"</span>, <span class="st">"ETHNIC"</span>, <span class="st">"RACE"</span>, <span class="st">"DIABPBL"</span><span class="op">)</span>, auto_pre <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         A: Drug X    B: Placebo    C: Combination   All Patients</span></span>
<span><span class="co">#&gt;                                          (N=134)       (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age                                                                                           </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Mean (SD)                          33.8 (6.6)    35.4 (7.9)      35.4 (7.7)      34.9 (7.4) </span></span>
<span><span class="co">#&gt;     Median                                33.0          35.0            35.0            34.0    </span></span>
<span><span class="co">#&gt;     Min - Max                          21.0 - 50.0   21.0 - 62.0    20.0 - 69.0     20.0 - 69.0 </span></span>
<span><span class="co">#&gt;   Age Group                                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     &lt;65                                134 (100%)    134 (100%)     131 (99.2%)     399 (99.8%) </span></span>
<span><span class="co">#&gt;     &gt;=65                                    0             0           1 (0.8%)        1 (0.2%)  </span></span>
<span><span class="co">#&gt;   Sex                                                                                           </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Male                               55 (41.0%)    52 (38.8%)      62 (47.0%)     169 (42.2%) </span></span>
<span><span class="co">#&gt;     Female                             79 (59.0%)    82 (61.2%)      70 (53.0%)     231 (57.8%) </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     NOT REPORTED                        6 (4.5%)      10 (7.5%)      11 (8.3%)       27 (6.8%)  </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                 15 (11.2%)    18 (13.4%)      15 (11.4%)      48 (12.0%) </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO             104 (77.6%)   103 (76.9%)    101 (76.5%)     308 (77.0%) </span></span>
<span><span class="co">#&gt;     UNKNOWN                             9 (6.7%)      3 (2.2%)        5 (3.8%)       17 (4.2%)  </span></span>
<span><span class="co">#&gt;   RACE                                                                                          </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE    8 (6.0%)      11 (8.2%)       6 (4.5%)       25 (6.2%)  </span></span>
<span><span class="co">#&gt;     ASIAN                              68 (50.7%)    68 (50.7%)      73 (55.3%)     209 (52.2%) </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN          31 (23.1%)    28 (20.9%)      32 (24.2%)      91 (22.8%) </span></span>
<span><span class="co">#&gt;     WHITE                              27 (20.1%)    27 (20.1%)      21 (15.9%)      75 (18.8%) </span></span>
<span><span class="co">#&gt;   Analysis Value                                                                                </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Mean (SD)                          48.6 (8.0)    50.4 (7.9)      51.1 (7.8)      50.0 (8.0) </span></span>
<span><span class="co">#&gt;     Median                                48.4          50.2            50.8            50.0    </span></span>
<span><span class="co">#&gt;     Min - Max                          27.7 - 64.6   21.7 - 67.5    29.7 - 71.4     21.7 - 71.4</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="patient-disposition-dst01">
<strong>Patient Disposition (<code>DST01</code>)</strong><a class="anchor" aria-label="anchor" href="#patient-disposition-dst01"></a>
</h3>
<div class="section level4">
<h4 id="patient-disposition">
<strong>1. Patient Disposition</strong><a class="anchor" aria-label="anchor" href="#patient-disposition"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>dst01</code></strong> template produces the
standard patient disposition summary.<br>
</li>
<li>The template includes the column of total by default. Use
<code>lbl_overall = NULL</code> to suppress the default.</li>
</ol>
<div class="sourceCode" id="cb24"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dst01</span>, <span class="va">syn_data</span>, lbl_overall <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                                      (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Completed                         68 (50.7%)   66 (49.3%)     73 (55.3%)  </span></span>
<span><span class="co">#&gt;   Ongoing                           24 (17.9%)   28 (20.9%)     21 (15.9%)  </span></span>
<span><span class="co">#&gt;   Discontinued                      42 (31.3%)   40 (29.9%)     38 (28.8%)  </span></span>
<span><span class="co">#&gt;     ADVERSE EVENT                    3 (2.2%)     6 (4.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;     DEATH                           25 (18.7%)   23 (17.2%)     22 (16.7%)  </span></span>
<span><span class="co">#&gt;     LACK OF EFFICACY                 2 (1.5%)     2 (1.5%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;     PHYSICIAN DECISION               2 (1.5%)     3 (2.2%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;     PROTOCOL VIOLATION               5 (3.7%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    4 (3.0%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY SUBJECT            1 (0.7%)     1 (0.7%)       1 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="patient-disposition-with-grouping-of-reasons">
<strong>2. Patient Disposition (with grouping of
reasons)</strong><a class="anchor" aria-label="anchor" href="#patient-disposition-with-grouping-of-reasons"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The syntax below produces the standard patient disposition summary
with grouping of the discontinuation reasons.<br>
</li>
<li>The variable [<code>ADSL.DCSREASGP</code>] that groups the
discontinuation reasons needs to be derived manually and provided in the
input <code>adsl</code> dataset.</li>
</ol>
<div class="sourceCode" id="cb25"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dst01</span>, <span class="va">syn_data</span>, detail_vars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>Discontinued <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"DCSREASGP"</span>, <span class="st">"DCSREAS"</span><span class="op">)</span><span class="op">)</span>, lbl_overall <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                       A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                                        (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Completed                           68 (50.7%)   66 (49.3%)     73 (55.3%)  </span></span>
<span><span class="co">#&gt;   Ongoing                             24 (17.9%)   28 (20.9%)     21 (15.9%)  </span></span>
<span><span class="co">#&gt;   Discontinued                        42 (31.3%)   40 (29.9%)     38 (28.8%)  </span></span>
<span><span class="co">#&gt;     Safety                                                                    </span></span>
<span><span class="co">#&gt;       ADVERSE EVENT                    3 (2.2%)     6 (4.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;       DEATH                           25 (18.7%)   23 (17.2%)     22 (16.7%)  </span></span>
<span><span class="co">#&gt;     Non-Safety                                                                </span></span>
<span><span class="co">#&gt;       LACK OF EFFICACY                 2 (1.5%)     2 (1.5%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;       PHYSICIAN DECISION               2 (1.5%)     3 (2.2%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;       PROTOCOL VIOLATION               5 (3.7%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;       WITHDRAWAL BY PARENT/GUARDIAN    4 (3.0%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;       WITHDRAWAL BY SUBJECT            1 (0.7%)     1 (0.7%)       1 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="patient-disposition-adding-end-of-treatment-status">
<strong>3. Patient Disposition (adding end of treatment
status)</strong><a class="anchor" aria-label="anchor" href="#patient-disposition-adding-end-of-treatment-status"></a>
</h4>
<p>The syntax below adds the end of treatment status to the standard
patient disposition summary by providing the end of treatment status
variable to the parameter <code>trt_status_var</code>.</p>
<div class="sourceCode" id="cb26"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dst01</span>, <span class="va">syn_data</span>, trt_status_var <span class="op">=</span> <span class="st">"EOTSTT"</span>, lbl_overall <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                                      (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Completed                         68 (50.7%)   66 (49.3%)     73 (55.3%)  </span></span>
<span><span class="co">#&gt;   Ongoing                           24 (17.9%)   28 (20.9%)     21 (15.9%)  </span></span>
<span><span class="co">#&gt;   Discontinued                      42 (31.3%)   40 (29.9%)     38 (28.8%)  </span></span>
<span><span class="co">#&gt;     ADVERSE EVENT                    3 (2.2%)     6 (4.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;     DEATH                           25 (18.7%)   23 (17.2%)     22 (16.7%)  </span></span>
<span><span class="co">#&gt;     LACK OF EFFICACY                 2 (1.5%)     2 (1.5%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;     PHYSICIAN DECISION               2 (1.5%)     3 (2.2%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;     PROTOCOL VIOLATION               5 (3.7%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    4 (3.0%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY SUBJECT            1 (0.7%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;   Completed Treatment               47 (35.1%)   35 (26.1%)     42 (31.8%)  </span></span>
<span><span class="co">#&gt;   Ongoing Treatment                 39 (29.1%)   46 (34.3%)     46 (34.8%)  </span></span>
<span><span class="co">#&gt;   Discontinued Treatment            48 (35.8%)   53 (39.6%)     44 (33.3%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="patient-disposition-adding-details-of-study-ongoing-status">
<strong>4. Patient Disposition (adding details of study ongoing
status)</strong><a class="anchor" aria-label="anchor" href="#patient-disposition-adding-details-of-study-ongoing-status"></a>
</h4>
<p>The syntax adds the details of study ongoing/alive status to the
standard patient disposition summary by modifying the parameter
<code>detail_vars</code>.</p>
<div class="sourceCode" id="cb27"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dst01</span>, <span class="va">syn_data</span>, detail_vars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>Discontinued <span class="op">=</span> <span class="st">"DCSREAS"</span>, Ongoing <span class="op">=</span> <span class="st">"STDONS"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span><span class="co">#&gt;                                      (N=134)      (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Completed                         68 (50.7%)   66 (49.3%)     73 (55.3%)     207 (51.7%) </span></span>
<span><span class="co">#&gt;   Ongoing                           24 (17.9%)   28 (20.9%)     21 (15.9%)      73 (18.2%) </span></span>
<span><span class="co">#&gt;     Alive: Ongoing                   8 (6.0%)     6 (4.5%)       8 (6.1%)       22 (5.5%)  </span></span>
<span><span class="co">#&gt;     Alive: In Follow-up             16 (11.9%)   22 (16.4%)     13 (9.8%)       51 (12.8%) </span></span>
<span><span class="co">#&gt;   Discontinued                      42 (31.3%)   40 (29.9%)     38 (28.8%)     120 (30.0%) </span></span>
<span><span class="co">#&gt;     ADVERSE EVENT                    3 (2.2%)     6 (4.5%)       5 (3.8%)       14 (3.5%)  </span></span>
<span><span class="co">#&gt;     DEATH                           25 (18.7%)   23 (17.2%)     22 (16.7%)      70 (17.5%) </span></span>
<span><span class="co">#&gt;     LACK OF EFFICACY                 2 (1.5%)     2 (1.5%)       3 (2.3%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     PHYSICIAN DECISION               2 (1.5%)     3 (2.2%)       2 (1.5%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     PROTOCOL VIOLATION               5 (3.7%)     3 (2.2%)       4 (3.0%)       12 (3.0%)  </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    4 (3.0%)     2 (1.5%)       1 (0.8%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY SUBJECT            1 (0.7%)     1 (0.7%)       1 (0.8%)        3 (0.8%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="deaths-dtht01">
<strong>Deaths (<code>DTHT01</code>)</strong><a class="anchor" aria-label="anchor" href="#deaths-dtht01"></a>
</h3>
<div class="section level4">
<h4 id="deaths">
<strong>1. Deaths</strong><a class="anchor" aria-label="anchor" href="#deaths"></a>
</h4>
<p>The <strong><code>dtht01</code></strong> template produces the
standard deaths output.</p>
<div class="sourceCode" id="cb28"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dst01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span><span class="co">#&gt;                                      (N=134)      (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Completed                         68 (50.7%)   66 (49.3%)     73 (55.3%)     207 (51.7%) </span></span>
<span><span class="co">#&gt;   Ongoing                           24 (17.9%)   28 (20.9%)     21 (15.9%)      73 (18.2%) </span></span>
<span><span class="co">#&gt;   Discontinued                      42 (31.3%)   40 (29.9%)     38 (28.8%)     120 (30.0%) </span></span>
<span><span class="co">#&gt;     ADVERSE EVENT                    3 (2.2%)     6 (4.5%)       5 (3.8%)       14 (3.5%)  </span></span>
<span><span class="co">#&gt;     DEATH                           25 (18.7%)   23 (17.2%)     22 (16.7%)      70 (17.5%) </span></span>
<span><span class="co">#&gt;     LACK OF EFFICACY                 2 (1.5%)     2 (1.5%)       3 (2.3%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     PHYSICIAN DECISION               2 (1.5%)     3 (2.2%)       2 (1.5%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     PROTOCOL VIOLATION               5 (3.7%)     3 (2.2%)       4 (3.0%)       12 (3.0%)  </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    4 (3.0%)     2 (1.5%)       1 (0.8%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY SUBJECT            1 (0.7%)     1 (0.7%)       1 (0.8%)        3 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="deaths-adding-primary-cause-of-death-details-for-other-category">
<strong>2. Deaths (adding “Primary Cause of Death” details for
‘Other’ category)</strong><a class="anchor" aria-label="anchor" href="#deaths-adding-primary-cause-of-death-details-for-other-category"></a>
</h4>
<div class="sourceCode" id="cb29"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dtht01</span>, <span class="va">syn_data</span>, other_category <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                       A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                                        (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of deaths              25 (18.7%)   23 (17.2%)     22 (16.7%)  </span></span>
<span><span class="co">#&gt;   Primary Cause of Death                                                      </span></span>
<span><span class="co">#&gt;     n                                     25           23             22      </span></span>
<span><span class="co">#&gt;     Adverse Event                     9 (36.0%)    7 (30.4%)      10 (45.5%)  </span></span>
<span><span class="co">#&gt;     Progressive Disease               8 (32.0%)    6 (26.1%)      6 (27.3%)   </span></span>
<span><span class="co">#&gt;     Other                             8 (32.0%)    10 (43.5%)     6 (27.3%)   </span></span>
<span><span class="co">#&gt;       LOST TO FOLLOW UP                2 (8.3%)     2 (8.3%)       2 (8.3%)   </span></span>
<span><span class="co">#&gt;       MISSING                          2 (8.3%)    3 (12.5%)       2 (8.3%)   </span></span>
<span><span class="co">#&gt;       Post-study reporting of death    1 (4.2%)     2 (8.3%)       1 (4.2%)   </span></span>
<span><span class="co">#&gt;       SUICIDE                          2 (8.3%)     2 (8.3%)       1 (4.2%)   </span></span>
<span><span class="co">#&gt;       UNKNOWN                          1 (4.2%)     1 (4.2%)          0</span></span></code></pre></div>
<p>NOTE: In order to avoid the warning above and display ‘Other’ as the
last category under “Primary Cause of Death” right above the detailed
reasons for “Other”, the user is expected to manually provide levels to
<code>ADSL.DTHCAT</code> based on categories available in the
dataset.</p>
</div>
<div class="section level4">
<h4 id="deaths-adding-summary-by-days-from-last-study-drug-administration">
<strong>3. Deaths (adding summary by days from last study drug
administration)</strong><a class="anchor" aria-label="anchor" href="#deaths-adding-summary-by-days-from-last-study-drug-administration"></a>
</h4>
<p>Setting <code>time_since_last_dose</code> to <code>TRUE</code>, the
syntax produces the count of deaths by days from last study drug
administration as well as the count of deaths by primary cause and days
from last study drug administration.</p>
<div class="sourceCode" id="cb30"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dtht01</span>, <span class="va">syn_data</span>, time_since_last_dose <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                               A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                                                                (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of deaths                                      25 (18.7%)   23 (17.2%)     22 (16.7%)  </span></span>
<span><span class="co">#&gt;   Days from last drug administration                                                                  </span></span>
<span><span class="co">#&gt;     n                                                             25           23             22      </span></span>
<span><span class="co">#&gt;     &lt;=30                                                      14 (56.0%)   11 (47.8%)     14 (63.6%)  </span></span>
<span><span class="co">#&gt;     &gt;30                                                       11 (44.0%)   12 (52.2%)     8 (36.4%)   </span></span>
<span><span class="co">#&gt;   Primary cause by days from last study drug administration                                           </span></span>
<span><span class="co">#&gt;     &lt;=30                                                                                              </span></span>
<span><span class="co">#&gt;       n                                                           14           11             14      </span></span>
<span><span class="co">#&gt;       Adverse Event                                           4 (28.6%)    2 (18.2%)      6 (42.9%)   </span></span>
<span><span class="co">#&gt;       Progressive Disease                                     6 (42.9%)    3 (27.3%)      4 (28.6%)   </span></span>
<span><span class="co">#&gt;       Other                                                   4 (28.6%)    6 (54.5%)      4 (28.6%)   </span></span>
<span><span class="co">#&gt;     &gt;30                                                                                               </span></span>
<span><span class="co">#&gt;       n                                                           11           12             8       </span></span>
<span><span class="co">#&gt;       Adverse Event                                           5 (45.5%)    5 (41.7%)      4 (50.0%)   </span></span>
<span><span class="co">#&gt;       Progressive Disease                                     2 (18.2%)    3 (25.0%)      2 (25.0%)   </span></span>
<span><span class="co">#&gt;       Other                                                   4 (36.4%)    4 (33.3%)      2 (25.0%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="ecg-results-and-change-from-baseline-by-visit-egt01">
<strong>ECG Results and Change from Baseline by Visit
(<code>EGT01</code>)</strong><a class="anchor" aria-label="anchor" href="#ecg-results-and-change-from-baseline-by-visit-egt01"></a>
</h3>
<div class="section level4">
<h4 id="ecg-results-and-change-from-baseline-by-visit">
<strong>1. ECG Results and Change from Baseline by
Visit</strong><a class="anchor" aria-label="anchor" href="#ecg-results-and-change-from-baseline-by-visit"></a>
</h4>
<p>The <strong><code>egt01</code></strong> template produces the
standard ECG results and change from baseline by visit summary.</p>
<div class="sourceCode" id="cb31"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Analysis Visit                   A: Drug X                                B: Placebo                              C: Combination             </span></span>
<span><span class="co">#&gt;                                             Change from                               Change from                               Change from    </span></span>
<span><span class="co">#&gt;                       Value at Visit          Baseline          Value at Visit          Baseline          Value at Visit          Baseline     </span></span>
<span><span class="co">#&gt;                          (N=134)              (N=134)              (N=134)              (N=134)              (N=132)              (N=132)      </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Heart Rate                                                                                                                                   </span></span>
<span><span class="co">#&gt;     BASELINE                                                                                                                                   </span></span>
<span><span class="co">#&gt;       n                    134                                       134                                       132                             </span></span>
<span><span class="co">#&gt;       Mean (SD)      71.447 (17.932)                           69.829 (20.717)                           69.341 (20.948)                       </span></span>
<span><span class="co">#&gt;       Median              72.697                                    73.352                                    71.956                           </span></span>
<span><span class="co">#&gt;       Min - Max       9.09 - 106.91                             13.49 - 115.52                            11.63 - 115.49                       </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                               </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      70.191 (20.274)      -1.257 (25.966)      69.427 (20.799)      -0.401 (29.735)      68.654 (18.064)      -0.687 (27.807)  </span></span>
<span><span class="co">#&gt;       Median              70.703               -2.197               70.462               -0.520               68.573               -0.760      </span></span>
<span><span class="co">#&gt;       Min - Max       8.53 - 127.50        -50.97 - 89.16       16.85 - 129.14       -68.18 - 88.38       16.87 - 115.60       -68.25 - 67.20  </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      70.317 (19.561)      -1.130 (26.262)      71.108 (20.556)       1.279 (31.353)      69.193 (18.056)      -0.148 (28.606)  </span></span>
<span><span class="co">#&gt;       Median              70.885               -1.105               72.524               -0.311               69.304               -1.548      </span></span>
<span><span class="co">#&gt;       Min - Max       17.14 - 116.32       -85.03 - 67.52       9.22 - 120.54        -73.07 - 81.44       29.62 - 120.50       -67.75 - 66.29  </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      68.251 (20.168)      -3.196 (28.657)      68.947 (20.558)      -0.881 (30.142)      70.884 (20.280)       1.543 (27.285)  </span></span>
<span><span class="co">#&gt;       Median              68.787               -2.167               67.802               1.195                70.124               0.139       </span></span>
<span><span class="co">#&gt;       Min - Max       13.33 - 131.73       -81.20 - 72.57       23.98 - 130.41      -73.03 - 103.31       20.91 - 116.79       -64.51 - 72.52  </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      70.063 (18.410)      -1.385 (26.595)      71.601 (20.336)       1.772 (30.262)      71.020 (20.591)       1.679 (29.597)  </span></span>
<span><span class="co">#&gt;       Median              69.330               -4.535               72.211               -0.884               70.523               3.811       </span></span>
<span><span class="co">#&gt;       Min - Max       22.30 - 116.51       -58.07 - 77.32       17.53 - 129.06       -64.32 - 85.34       10.35 - 117.30      -65.91 - 105.67  </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      66.406 (19.745)      -5.041 (27.112)      71.252 (18.923)       1.423 (27.084)      71.257 (18.563)       1.916 (29.591)  </span></span>
<span><span class="co">#&gt;       Median              65.405               -6.827               70.858               0.637                73.292               1.735       </span></span>
<span><span class="co">#&gt;       Min - Max       23.89 - 110.38       -73.26 - 57.24       25.86 - 125.73       -71.15 - 67.37       23.89 - 117.19       -58.23 - 68.86  </span></span>
<span><span class="co">#&gt;   QT Duration                                                                                                                                  </span></span>
<span><span class="co">#&gt;     BASELINE                                                                                                                                   </span></span>
<span><span class="co">#&gt;       n                    134                                       134                                       132                             </span></span>
<span><span class="co">#&gt;       Mean (SD)     336.834 (117.958)                          351.004 (98.436)                         352.598 (105.114)                      </span></span>
<span><span class="co">#&gt;       Median             344.414                                   351.480                                   347.956                           </span></span>
<span><span class="co">#&gt;       Min - Max       86.98 - 665.40                            98.90 - 641.92                           105.68 - 628.14                       </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                               </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     342.574 (101.093)     5.741 (159.936)     363.946 (102.338)     12.943 (140.729)    359.424 (105.161)     6.826 (147.129)  </span></span>
<span><span class="co">#&gt;       Median             347.264               -1.779              356.539               13.730              363.838               8.685       </span></span>
<span><span class="co">#&gt;       Min - Max       91.63 - 591.42      -346.44 - 452.75     114.92 - 656.45      -317.53 - 416.35      51.91 - 611.88      -473.19 - 358.00 </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      353.244 (93.926)     16.410 (162.103)     345.926 (96.783)     -5.078 (152.509)     335.689 (98.605)    -16.909 (138.448) </span></span>
<span><span class="co">#&gt;       Median             351.099               16.722              346.831               -9.681              320.957              -22.267      </span></span>
<span><span class="co">#&gt;       Min - Max      138.01 - 587.30      -414.07 - 389.16     146.42 - 556.07      -440.28 - 364.76     104.91 - 562.34      -326.55 - 325.27 </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     370.115 (101.568)     33.282 (152.780)    343.412 (102.585)     -7.592 (138.803)     346.947 (94.965)     -5.652 (144.651) </span></span>
<span><span class="co">#&gt;       Median             378.209               39.586              335.119              -15.888              352.154               9.113       </span></span>
<span><span class="co">#&gt;       Min - Max      118.14 - 615.18      -391.72 - 520.09      63.37 - 566.51      -311.28 - 293.76     126.09 - 580.81      -412.11 - 410.01 </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      345.774 (95.970)     8.941 (145.647)     354.377 (108.286)     3.374 (142.390)     341.358 (106.745)    -11.240 (145.648) </span></span>
<span><span class="co">#&gt;       Median             340.134               5.576               346.699              -17.129              352.295              -11.868      </span></span>
<span><span class="co">#&gt;       Min - Max      110.12 - 616.58      -393.34 - 456.04      80.82 - 687.69      -439.90 - 364.80      4.95 - 570.61       -480.94 - 330.67 </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      358.903 (97.693)     22.069 (155.681)     338.648 (99.260)    -12.356 (130.457)     349.303 (95.769)     -3.296 (135.997) </span></span>
<span><span class="co">#&gt;       Median             351.959               5.886               344.167               0.405               350.319               12.680      </span></span>
<span><span class="co">#&gt;       Min - Max       88.38 - 661.12      -353.30 - 539.84      31.25 - 563.90      -338.85 - 352.75     119.02 - 581.83      -311.45 - 295.53 </span></span>
<span><span class="co">#&gt;   RR Duration                                                                                                                                  </span></span>
<span><span class="co">#&gt;     BASELINE                                                                                                                                   </span></span>
<span><span class="co">#&gt;       n                    134                                       134                                       132                             </span></span>
<span><span class="co">#&gt;       Mean (SD)     1028.419 (286.385)                        1027.484 (324.000)                        1074.623 (277.328)                     </span></span>
<span><span class="co">#&gt;       Median             1041.860                                  1047.268                                  1080.866                          </span></span>
<span><span class="co">#&gt;       Min - Max      34.33 - 1783.71                            5.29 - 1877.19                           289.60 - 1617.06                      </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                               </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     990.155 (318.736)    -38.264 (446.403)    1061.587 (269.138)    34.103 (401.759)    1039.642 (284.389)   -34.981 (406.037) </span></span>
<span><span class="co">#&gt;       Median             963.881              -86.501              1061.504              66.914              1014.780             -97.826      </span></span>
<span><span class="co">#&gt;       Min - Max      110.82 - 2014.56    -1014.82 - 1389.40    276.83 - 1711.99     -942.16 - 993.82     498.21 - 1937.47     -958.61 - 908.90 </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     1013.371 (304.135)   -15.047 (425.807)    1109.402 (318.227)    81.918 (453.105)    1045.209 (277.506)   -29.414 (380.841) </span></span>
<span><span class="co">#&gt;       Median             1040.693              40.485              1117.764              69.275              1034.637             -15.331      </span></span>
<span><span class="co">#&gt;       Min - Max      164.19 - 1677.10    -1216.10 - 1053.15    160.73 - 2048.73    -1127.10 - 1148.61    252.84 - 1722.33     -859.27 - 871.54 </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     1013.987 (304.990)   -14.431 (406.529)    1118.345 (296.527)    90.861 (409.573)    1036.593 (268.521)   -38.030 (421.484) </span></span>
<span><span class="co">#&gt;       Median             1027.232             -50.543              1134.596              52.029              1030.717             -60.720      </span></span>
<span><span class="co">#&gt;       Min - Max      357.04 - 1798.65    -882.94 - 1080.26     97.14 - 1825.43     -887.06 - 1166.15     446.02 - 1713.38     -984.79 - 902.37 </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     1033.309 (313.919)    4.890 (483.153)     1079.762 (298.940)    52.278 (429.253)    1027.549 (295.856)   -47.074 (378.235) </span></span>
<span><span class="co">#&gt;       Median             1050.399              5.601               1051.613              69.554              1023.360             -49.519      </span></span>
<span><span class="co">#&gt;       Min - Max      54.33 - 1979.43     -1345.93 - 1195.41    347.94 - 1762.04    -826.43 - 1191.83     341.62 - 2144.86    -1002.03 - 1048.66</span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     1072.335 (282.901)    43.916 (379.048)    1058.452 (271.012)    30.968 (436.030)    1029.043 (271.211)   -45.580 (405.528) </span></span>
<span><span class="co">#&gt;       Median             1067.330              55.872              1068.950              33.615              1065.256             -34.395      </span></span>
<span><span class="co">#&gt;       Min - Max      352.97 - 2000.56    -1028.79 - 1418.57    208.83 - 1794.73    -978.97 - 1365.13     436.28 - 1794.07    -962.18 - 1329.88</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="ecg-abnormalities-regardless-of-abnormality-at-baseline-egt02_1">
<strong>ECG Abnormalities (Regardless of Abnormality at Baseline)
(<code>EGT02_1</code>)</strong><a class="anchor" aria-label="anchor" href="#ecg-abnormalities-regardless-of-abnormality-at-baseline-egt02_1"></a>
</h3>
<div class="section level4">
<h4 id="ecg-abnormalities-regardless-of-abnormality-at-baseline">
<strong>1. ECG Abnormalities (Regardless of Abnormality at
Baseline)</strong><a class="anchor" aria-label="anchor" href="#ecg-abnormalities-regardless-of-abnormality-at-baseline"></a>
</h4>
<p>The <strong><code>egt02_1</code></strong> template produces the
standard ECG abnormalities summary where the abnormalities are
summarized regardless of the abnormality at baseline.</p>
<div class="sourceCode" id="cb32"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt02_1</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Assessment       A: Drug X        B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;    Abnormality      (N=134)          (N=134)          (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Heart Rate                                                     </span></span>
<span><span class="co">#&gt;     Low          49/134 (36.6%)   57/134 (42.5%)   55/132 (41.7%)</span></span>
<span><span class="co">#&gt;     High         48/134 (35.8%)   51/134 (38.1%)   48/132 (36.4%)</span></span>
<span><span class="co">#&gt;   QT Duration                                                    </span></span>
<span><span class="co">#&gt;     Low          53/134 (39.6%)   56/134 (41.8%)   54/132 (40.9%)</span></span>
<span><span class="co">#&gt;     High         45/134 (33.6%)   51/134 (38.1%)   45/132 (34.1%)</span></span>
<span><span class="co">#&gt;   RR Duration                                                    </span></span>
<span><span class="co">#&gt;     Low          56/134 (41.8%)   41/134 (30.6%)   50/132 (37.9%)</span></span>
<span><span class="co">#&gt;     High         39/134 (29.1%)   62/134 (46.3%)   41/132 (31.1%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="ecg-abnormalities-among-subject-without-abnormality-at-baseline-egt02_2">
<strong>ECG Abnormalities (Among Subject Without Abnormality at
Baseline) (<code>EGT02_2</code>)</strong><a class="anchor" aria-label="anchor" href="#ecg-abnormalities-among-subject-without-abnormality-at-baseline-egt02_2"></a>
</h3>
<div class="section level4">
<h4 id="ecg-abnormalities-among-subject-without-abnormality-at-baseline">
<strong>1. ECG Abnormalities (Among Subject Without Abnormality at
Baseline)</strong><a class="anchor" aria-label="anchor" href="#ecg-abnormalities-among-subject-without-abnormality-at-baseline"></a>
</h4>
<p>The <strong><code>egt02_2</code></strong> template produces the
standard ECG abnormalities summary where the abnormalities are
summarized among subject without abnormality at baseline.</p>
<div class="sourceCode" id="cb33"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt02_2</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Assessment       A: Drug X        B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;    Abnormality      (N=134)          (N=134)          (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Heart Rate                                                     </span></span>
<span><span class="co">#&gt;     Low          43/128 (33.6%)   47/124 (37.9%)   40/117 (34.2%)</span></span>
<span><span class="co">#&gt;     High         41/127 (32.3%)   46/129 (35.7%)   38/122 (31.1%)</span></span>
<span><span class="co">#&gt;   QT Duration                                                    </span></span>
<span><span class="co">#&gt;     Low          32/113 (28.3%)   48/126 (38.1%)   46/124 (37.1%)</span></span>
<span><span class="co">#&gt;     High         36/125 (28.8%)   47/130 (36.2%)   33/119 (27.7%)</span></span>
<span><span class="co">#&gt;   RR Duration                                                    </span></span>
<span><span class="co">#&gt;     Low          51/129 (39.5%)   30/123 (24.4%)   44/126 (34.9%)</span></span>
<span><span class="co">#&gt;     High         32/127 (25.2%)    50/122 (41%)    34/125 (27.2%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="shift-table-of-ecg-interval-data---baseline-versus-minimummaximum-post-baseline-egt03">
<strong>Shift Table of ECG Interval Data - Baseline versus
Minimum/Maximum Post-Baseline (<code>EGT03</code>)</strong><a class="anchor" aria-label="anchor" href="#shift-table-of-ecg-interval-data---baseline-versus-minimummaximum-post-baseline-egt03"></a>
</h3>
<div class="section level4">
<h4 id="shift-table-of-ecg-interval-data---baseline-versus-minimum-post-baseline">
<strong>1. Shift Table of ECG Interval Data - Baseline versus
Minimum Post-Baseline</strong><a class="anchor" aria-label="anchor" href="#shift-table-of-ecg-interval-data---baseline-versus-minimum-post-baseline"></a>
</h4>
<p>The <strong><code>egt03</code></strong> template produces the
standard shift table of ECG interval data - baseline versus minimum
post-baseline summary.</p>
<div class="sourceCode" id="cb34"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"HR"</span>, <span class="st">"adeg"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt03</span>, <span class="va">proc_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Actual Arm Code                            Minimum Post-Baseline Assessment     </span></span>
<span><span class="co">#&gt;     Baseline Reference Range Indicator       LOW         NORMAL     HIGH   Missing</span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   ARM A (N=134)                                                                   </span></span>
<span><span class="co">#&gt;     LOW                                   1 (0.7%)      5 (3.7%)     0        0   </span></span>
<span><span class="co">#&gt;     NORMAL                               36 (26.9%)    85 (63.4%)    0        0   </span></span>
<span><span class="co">#&gt;     HIGH                                  3 (2.2%)       4 (3%)      0        0   </span></span>
<span><span class="co">#&gt;     Missing                                   0            0         0        0   </span></span>
<span><span class="co">#&gt;   ARM B (N=134)                                                                   </span></span>
<span><span class="co">#&gt;     LOW                                   1 (0.7%)      9 (6.7%)     0        0   </span></span>
<span><span class="co">#&gt;     NORMAL                               41 (30.6%)    78 (58.2%)    0        0   </span></span>
<span><span class="co">#&gt;     HIGH                                  1 (0.7%)       4 (3%)      0        0   </span></span>
<span><span class="co">#&gt;     Missing                                   0            0         0        0   </span></span>
<span><span class="co">#&gt;   ARM C (N=132)                                                                   </span></span>
<span><span class="co">#&gt;     LOW                                    4 (3%)      11 (8.3%)     0        0   </span></span>
<span><span class="co">#&gt;     NORMAL                               32 (24.2%)    75 (56.8%)    0        0   </span></span>
<span><span class="co">#&gt;     HIGH                                  1 (0.8%)      9 (6.8%)     0        0   </span></span>
<span><span class="co">#&gt;     Missing                                   0            0         0        0</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="shift-table-of-ecg-interval-data---baseline-versus-maximum-post-baseline">
<strong>2. Shift Table of ECG Interval Data - Baseline versus
Maximum Post-Baseline</strong><a class="anchor" aria-label="anchor" href="#shift-table-of-ecg-interval-data---baseline-versus-maximum-post-baseline"></a>
</h4>
<p>To produce the standard shift table of ECG interval data - baseline
versus maximum post-baseline summary….TBA</p>
</div>
</div>
<div class="section level3">
<h3 id="ecg-actual-values-and-changes-from-baseline-by-visit-egt05_qtcat">
<strong>ECG Actual Values and Changes from Baseline by Visit
(<code>EGT05_QTCAT</code>)</strong><a class="anchor" aria-label="anchor" href="#ecg-actual-values-and-changes-from-baseline-by-visit-egt05_qtcat"></a>
</h3>
<div class="section level4">
<h4 id="ecg-actual-values-and-changes-from-baseline-by-visit">
<strong>1. ECG Actual Values and Changes from Baseline by
Visit</strong><a class="anchor" aria-label="anchor" href="#ecg-actual-values-and-changes-from-baseline-by-visit"></a>
</h4>
<p>The <strong><code>egt05_qtcat</code></strong> template produces the
standard ECG actual values and changes from baseline by visit
summary.</p>
<div class="sourceCode" id="cb35"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt05_qtcat</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                            </span></span>
<span><span class="co">#&gt;     Analysis Visit            A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;       Category                 (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   QT Duration                                                          </span></span>
<span><span class="co">#&gt;     BASELINE                                                           </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           115 (85.8%)   117 (87.3%)    104 (78.8%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec    6 (4.5%)      10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    4 (3.0%)      3 (2.2%)        6 (4.5%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             9 (6.7%)      4 (3.0%)       13 (9.8%)   </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                       </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           113 (84.3%)   106 (79.1%)    106 (80.3%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec    10 (7.5%)     10 (7.5%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    4 (3.0%)      4 (3.0%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             7 (5.2%)     14 (10.4%)      12 (9.1%)   </span></span>
<span><span class="co">#&gt;       Change from Baseline                                             </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=30 msec            76 (56.7%)    75 (56.0%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;         &gt;30 to &lt;=60 msec      7 (5.2%)      13 (9.7%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;         &gt;60 msec             51 (38.1%)    46 (34.3%)      46 (34.8%)  </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                      </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           111 (82.8%)   114 (85.1%)    112 (84.8%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec    10 (7.5%)     9 (6.7%)        9 (6.8%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    7 (5.2%)      2 (1.5%)        5 (3.8%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             6 (4.5%)      9 (6.7%)        6 (4.5%)   </span></span>
<span><span class="co">#&gt;       Change from Baseline                                             </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=30 msec            71 (53.0%)    87 (64.9%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;         &gt;30 to &lt;=60 msec      11 (8.2%)     9 (6.7%)        9 (6.8%)   </span></span>
<span><span class="co">#&gt;         &gt;60 msec             52 (38.8%)    38 (28.4%)      34 (25.8%)  </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                      </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           106 (79.1%)   112 (83.6%)    118 (89.4%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec    13 (9.7%)     7 (5.2%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    4 (3.0%)      5 (3.7%)        2 (1.5%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             11 (8.2%)     10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;       Change from Baseline                                             </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=30 msec            63 (47.0%)    80 (59.7%)      81 (61.4%)  </span></span>
<span><span class="co">#&gt;         &gt;30 to &lt;=60 msec     14 (10.4%)     8 (6.0%)       11 (8.3%)   </span></span>
<span><span class="co">#&gt;         &gt;60 msec             57 (42.5%)    46 (34.3%)      40 (30.3%)  </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                      </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           117 (87.3%)   103 (76.9%)    114 (86.4%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec    7 (5.2%)     14 (10.4%)       6 (4.5%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    4 (3.0%)      7 (5.2%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             6 (4.5%)      10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;       Change from Baseline                                             </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=30 msec            79 (59.0%)    80 (59.7%)      79 (59.8%)  </span></span>
<span><span class="co">#&gt;         &gt;30 to &lt;=60 msec      11 (8.2%)     7 (5.2%)       10 (7.6%)   </span></span>
<span><span class="co">#&gt;         &gt;60 msec             44 (32.8%)    47 (35.1%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                      </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           107 (79.9%)   117 (87.3%)    112 (84.8%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec   16 (11.9%)     5 (3.7%)       13 (9.8%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    5 (3.7%)      9 (6.7%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             6 (4.5%)      3 (2.2%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;       Change from Baseline                                             </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=30 msec            72 (53.7%)    82 (61.2%)      73 (55.3%)  </span></span>
<span><span class="co">#&gt;         &gt;30 to &lt;=60 msec      10 (7.5%)     11 (8.2%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;         &gt;60 msec             52 (38.8%)    41 (30.6%)      48 (36.4%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="ecg-actual-values-and-changes-from-baseline-by-visit-removing-default-analyses">
<strong>2. ECG Actual Values and Changes from Baseline by Visit
(removing default analyses)</strong><a class="anchor" aria-label="anchor" href="#ecg-actual-values-and-changes-from-baseline-by-visit-removing-default-analyses"></a>
</h4>
<p>The template have two default analyses of <code>ADEG.AVALCAT1</code>
and <code>ADEG.CHGCAT1</code>. To keep only the analyses needed, this
can be achieved by modifying the parameter <code>summaryvars</code>.</p>
<div class="sourceCode" id="cb36"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt05_qtcat</span>, <span class="va">syn_data</span>, summaryvars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AVALCAT1"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                          </span></span>
<span><span class="co">#&gt;     Analysis Visit          A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;       Category               (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   QT Duration                                                        </span></span>
<span><span class="co">#&gt;     BASELINE                                                         </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           115 (85.8%)   117 (87.3%)    104 (78.8%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec    6 (4.5%)      10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    4 (3.0%)      3 (2.2%)        6 (4.5%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             9 (6.7%)      4 (3.0%)       13 (9.8%)   </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                     </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           113 (84.3%)   106 (79.1%)    106 (80.3%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec    10 (7.5%)     10 (7.5%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    4 (3.0%)      4 (3.0%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             7 (5.2%)     14 (10.4%)      12 (9.1%)   </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                    </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           111 (82.8%)   114 (85.1%)    112 (84.8%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec    10 (7.5%)     9 (6.7%)        9 (6.8%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    7 (5.2%)      2 (1.5%)        5 (3.8%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             6 (4.5%)      9 (6.7%)        6 (4.5%)   </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                    </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           106 (79.1%)   112 (83.6%)    118 (89.4%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec    13 (9.7%)     7 (5.2%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    4 (3.0%)      5 (3.7%)        2 (1.5%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             11 (8.2%)     10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                    </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           117 (87.3%)   103 (76.9%)    114 (86.4%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec    7 (5.2%)     14 (10.4%)       6 (4.5%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    4 (3.0%)      7 (5.2%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             6 (4.5%)      10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                    </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           107 (79.9%)   117 (87.3%)    112 (84.8%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec   16 (11.9%)     5 (3.7%)       13 (9.8%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    5 (3.7%)      9 (6.7%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             6 (4.5%)      3 (2.2%)        4 (3.0%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="study-drug-exposure-ext01">
<strong>Study Drug Exposure (<code>EXT01</code>)</strong><a class="anchor" aria-label="anchor" href="#study-drug-exposure-ext01"></a>
</h3>
<div class="section level4">
<h4 id="study-drug-exposure">
<strong>1. Study Drug Exposure</strong><a class="anchor" aria-label="anchor" href="#study-drug-exposure"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>ext01</code></strong> template displays total
number of doses administered and total dose administered by default</li>
<li>The template does not include the column of total by default</li>
</ol>
<div class="sourceCode" id="cb37"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ext01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   PARCAT2                        A: Drug X        B: Placebo      C: Combination </span></span>
<span><span class="co">#&gt;                                   (N=134)           (N=134)           (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Drug A                                                                         </span></span>
<span><span class="co">#&gt;     Overall duration (days)                                                      </span></span>
<span><span class="co">#&gt;       n                             75                67                75       </span></span>
<span><span class="co">#&gt;       Mean (SD)                121.5 (70.7)      131.2 (78.5)      130.5 (73.1)  </span></span>
<span><span class="co">#&gt;       Median                       116.0             127.0             126.0     </span></span>
<span><span class="co">#&gt;       Min - Max                15.0 - 249.0       1.0 - 250.0       1.0 - 246.0  </span></span>
<span><span class="co">#&gt;     Total dose administered                                                      </span></span>
<span><span class="co">#&gt;       n                             75                67                75       </span></span>
<span><span class="co">#&gt;       Mean (SD)               6675.2 (1110.9)   6505.1 (1249.3)   6982.4 (1272.5)</span></span>
<span><span class="co">#&gt;       Median                      6720.0            6480.0            7200.0     </span></span>
<span><span class="co">#&gt;       Min - Max               4800.0 - 9360.0   4080.0 - 9360.0   4320.0 - 9360.0</span></span>
<span><span class="co">#&gt;   Drug B                                                                         </span></span>
<span><span class="co">#&gt;     Overall duration (days)                                                      </span></span>
<span><span class="co">#&gt;       n                             59                67                57       </span></span>
<span><span class="co">#&gt;       Mean (SD)                111.0 (69.4)      113.7 (68.9)      137.5 (74.4)  </span></span>
<span><span class="co">#&gt;       Median                       98.0              104.0             144.0     </span></span>
<span><span class="co">#&gt;       Min - Max                 9.0 - 245.0       2.0 - 247.0      15.0 - 250.0  </span></span>
<span><span class="co">#&gt;     Total dose administered                                                      </span></span>
<span><span class="co">#&gt;       n                             59                67                57       </span></span>
<span><span class="co">#&gt;       Mean (SD)               6630.5 (1334.0)   6297.3 (1291.1)   6505.3 (1080.7)</span></span>
<span><span class="co">#&gt;       Median                      6720.0            6240.0            6480.0     </span></span>
<span><span class="co">#&gt;       Min - Max               4320.0 - 8880.0   4080.0 - 9120.0   4320.0 - 8640.0</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-test-results-and-change-from-baseline-by-visit-lbt01">
<strong>Laboratory Test Results and Change from Baseline by Visit
(<code>LBT01</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-and-change-from-baseline-by-visit-lbt01"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-test-results-and-change-from-baseline-by-visit">
<strong>1. Laboratory Test Results and Change from Baseline by
Visit</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-and-change-from-baseline-by-visit"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt01</code></strong> template produces the
standard laboratory test results and change from baseline by
visit.<br>
</li>
<li>To select the SI/CV/LS results and the panel
(chemistry/hematology/urinalysis/coagulation etc.) to display, user
defines individual filters and apply to input datasets prior to running
CHEVRON.</li>
</ol>
<div class="sourceCode" id="cb38"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">t_lb_chg</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/utils/head.html" class="external-link">head</a></span><span class="op">(</span><span class="va">t_lb_chg</span>, <span class="fl">20</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                     A: Drug X                        B: Placebo                      C: Combination         </span></span>
<span><span class="co">#&gt;                                                            Change from                       Change from                       Change from  </span></span>
<span><span class="co">#&gt;                                          Value at Visit      Baseline      Value at Visit      Baseline      Value at Visit      Baseline   </span></span>
<span><span class="co">#&gt;                                             (N=134)          (N=134)          (N=134)          (N=134)          (N=132)          (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                                                                                      </span></span>
<span><span class="co">#&gt;     BASELINE                                                                                                                                </span></span>
<span><span class="co">#&gt;       n                                       134                               134                               132                       </span></span>
<span><span class="co">#&gt;       Mean (SD)                          19.786 (4.161)                    20.153 (4.171)                    20.451 (3.911)                 </span></span>
<span><span class="co">#&gt;       Median                                 19.786                            20.077                            20.387                     </span></span>
<span><span class="co">#&gt;       Min - Max                           6.99 - 30.43                      8.11 - 34.56                      8.82 - 28.72                  </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                            </span></span>
<span><span class="co">#&gt;       n                                       134              134              134              134              132              132      </span></span>
<span><span class="co">#&gt;       Mean (SD)                          19.301 (3.981)   -0.485 (5.850)   20.221 (3.974)   0.068 (6.036)    20.553 (3.895)   0.102 (5.461) </span></span>
<span><span class="co">#&gt;       Median                                 19.209           -0.511           20.090           -0.725           20.402           0.025     </span></span>
<span><span class="co">#&gt;       Min - Max                           8.86 - 27.32    -12.52 - 19.70    5.84 - 28.75    -12.29 - 17.41    9.87 - 30.70    -13.69 - 15.54</span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                           </span></span>
<span><span class="co">#&gt;       n                                       134              134              134              134              132              132      </span></span>
<span><span class="co">#&gt;       Mean (SD)                          19.704 (4.233)   -0.082 (6.003)   20.123 (4.265)   -0.030 (6.263)   19.247 (3.592)   -1.204 (5.485)</span></span>
<span><span class="co">#&gt;       Median                                 19.168           0.038            19.986           -0.371           19.608           -0.482    </span></span>
<span><span class="co">#&gt;       Min - Max                           7.17 - 30.53    -13.15 - 17.17    7.19 - 30.54    -18.37 - 14.39    8.11 - 26.68    -14.28 - 15.65</span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                           </span></span>
<span><span class="co">#&gt;       n                                       134              134              134              134              132              132      </span></span>
<span><span class="co">#&gt;       Mean (SD)                          20.130 (3.757)   0.344 (5.761)    19.837 (3.871)   -0.316 (5.604)   19.428 (3.944)   -1.023 (5.550)</span></span>
<span><span class="co">#&gt;       Median                                 20.044           0.451            19.873           -0.178           18.838           -1.065</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-test-results-and-change-from-baseline-by-visit-customized-precision">
<strong>2. Laboratory Test Results and Change from Baseline by Visit
(customized precision)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-and-change-from-baseline-by-visit-customized-precision"></a>
</h4>
<p>TBA</p>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-abnormalities-lbt04">
<strong>Laboratory Abnormalities (<code>LBT04</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-lbt04"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-abnormalities">
<strong>1. Laboratory Abnormalities</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt04</code></strong> template produces the
standard laboratory abnormalities summary.<br>
</li>
<li>The template subsets to SI results by default.<br>
</li>
<li>The laboratory tests and directions of abnormality in this template
is data-driven. Table entries provide the number of patients with a
during treatment laboratory value abnormality in the direction specified
among patients without this abnormality at baseline.</li>
</ol>
<div class="sourceCode" id="cb39"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt04</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Laboratory Test                           A: Drug X      B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;       Direction of Abnormality               (N=134)        (N=134)         (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   CHEMISTRY                                                                            </span></span>
<span><span class="co">#&gt;     Alanine Aminotransferase Measurement                                               </span></span>
<span><span class="co">#&gt;       Low                                  7/45 (15.6%)   6/51 (11.8%)    4/61 (6.6%)  </span></span>
<span><span class="co">#&gt;       High                                 4/45 (8.9%)    6/45 (13.3%)    4/62 (6.5%)  </span></span>
<span><span class="co">#&gt;     C-Reactive Protein Measurement                                                     </span></span>
<span><span class="co">#&gt;       Low                                  6/55 (10.9%)   5/61 (8.2%)     6/51 (11.8%) </span></span>
<span><span class="co">#&gt;       High                                 6/53 (11.3%)   7/55 (12.7%)    2/48 (4.2%)  </span></span>
<span><span class="co">#&gt;     Immunoglobulin A Measurement                                                       </span></span>
<span><span class="co">#&gt;       Low                                  4/43 (9.3%)    9/51 (17.6%)    8/52 (15.4%) </span></span>
<span><span class="co">#&gt;       High                                 7/42 (16.7%)   7/49 (14.3%)    5/52 (9.6%)  </span></span>
<span><span class="co">#&gt;   COAGULATION                                                                          </span></span>
<span><span class="co">#&gt;     Alanine Aminotransferase Measurement                                               </span></span>
<span><span class="co">#&gt;       Low                                  4/54 (7.4%)    5/53 (9.4%)     4/48 (8.3%)  </span></span>
<span><span class="co">#&gt;       High                                 9/53 (17.0%)   7/50 (14.0%)    6/48 (12.5%) </span></span>
<span><span class="co">#&gt;     C-Reactive Protein Measurement                                                     </span></span>
<span><span class="co">#&gt;       Low                                  7/56 (12.5%)   5/48 (10.4%)    5/50 (10.0%) </span></span>
<span><span class="co">#&gt;       High                                 8/52 (15.4%)   3/46 (6.5%)     5/46 (10.9%) </span></span>
<span><span class="co">#&gt;     Immunoglobulin A Measurement                                                       </span></span>
<span><span class="co">#&gt;       Low                                  8/50 (16.0%)   8/57 (14.0%)    2/54 (3.7%)  </span></span>
<span><span class="co">#&gt;       High                                 6/48 (12.5%)   8/65 (12.3%)    2/52 (3.8%)  </span></span>
<span><span class="co">#&gt;   HEMATOLOGY                                                                           </span></span>
<span><span class="co">#&gt;     Alanine Aminotransferase Measurement                                               </span></span>
<span><span class="co">#&gt;       Low                                  3/48 (6.2%)    4/46 (8.7%)     6/59 (10.2%) </span></span>
<span><span class="co">#&gt;       High                                 5/47 (10.6%)   7/45 (15.6%)    8/55 (14.5%) </span></span>
<span><span class="co">#&gt;     C-Reactive Protein Measurement                                                     </span></span>
<span><span class="co">#&gt;       Low                                  6/49 (12.2%)   6/45 (13.3%)   11/57 (19.3%) </span></span>
<span><span class="co">#&gt;       High                                 3/44 (6.8%)    3/46 (6.5%)     6/53 (11.3%) </span></span>
<span><span class="co">#&gt;     Immunoglobulin A Measurement                                                       </span></span>
<span><span class="co">#&gt;       Low                                  5/56 (8.9%)    8/53 (15.1%)    9/50 (18.0%) </span></span>
<span><span class="co">#&gt;       High                                 7/57 (12.3%)   4/56 (7.1%)    10/52 (19.2%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-abnormalities-with-single-and-replicated-marked-lbt05">
<strong>Laboratory Abnormalities with Single and Replicated Marked
(<code>LBT05</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-with-single-and-replicated-marked-lbt05"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-abnormalities-with-single-and-replicated-marked">
<strong>1. Laboratory Abnormalities with Single and Replicated
Marked</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-with-single-and-replicated-marked"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt05</code></strong> template produces the
standard laboratory abnormalities summary for marked
abnormalities.<br>
</li>
<li>The laboratory tests and directions of abnormality in this template
is currently data-driven. The standard metadata for Safety Lab
Standardization will be incorporated in future release.</li>
</ol>
<div class="sourceCode" id="cb40"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt05</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Laboratory Test                            A: Drug X   B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;       Direction of Abnormality                (N=134)     (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement (n)      119         122            111      </span></span>
<span><span class="co">#&gt;     Low                                                                             </span></span>
<span><span class="co">#&gt;       Single, not last                       1 (0.8%)     2 (1.6%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     2 (1.7%)     7 (5.7%)          0       </span></span>
<span><span class="co">#&gt;       Any Abnormality                        3 (2.5%)     9 (7.4%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;     High                                                                            </span></span>
<span><span class="co">#&gt;       Single, not last                       4 (3.4%)     4 (3.3%)       1 (0.9%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     2 (1.7%)     5 (4.1%)       4 (3.6%)   </span></span>
<span><span class="co">#&gt;       Any Abnormality                        6 (5.0%)     9 (7.4%)       5 (4.5%)   </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement (n)            124         114            114      </span></span>
<span><span class="co">#&gt;     Low                                                                             </span></span>
<span><span class="co">#&gt;       Single, not last                       1 (0.8%)        0           3 (2.6%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     5 (4.0%)     6 (5.3%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;       Any Abnormality                        6 (4.8%)     6 (5.3%)       5 (4.4%)   </span></span>
<span><span class="co">#&gt;     High                                                                            </span></span>
<span><span class="co">#&gt;       Single, not last                       2 (1.6%)     1 (0.9%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     5 (4.0%)     5 (4.4%)       5 (4.4%)   </span></span>
<span><span class="co">#&gt;       Any Abnormality                        7 (5.6%)     6 (5.3%)       7 (6.1%)   </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement (n)              112         116            113      </span></span>
<span><span class="co">#&gt;     Low                                                                             </span></span>
<span><span class="co">#&gt;       Single, not last                       1 (0.9%)     3 (2.6%)       4 (3.5%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     4 (3.6%)     3 (2.6%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;       Any Abnormality                        5 (4.5%)     6 (5.2%)       6 (5.3%)   </span></span>
<span><span class="co">#&gt;     High                                                                            </span></span>
<span><span class="co">#&gt;       Single, not last                       1 (0.9%)     1 (0.9%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     1 (0.9%)     5 (4.3%)       3 (2.7%)   </span></span>
<span><span class="co">#&gt;       Any Abnormality                        2 (1.8%)     6 (5.2%)       5 (4.4%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-abnormalities-with-single-and-replicated-marked-showing-all-categories">
<strong>2. Laboratory Abnormalities with Single and Replicated
Marked showing all categories</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-with-single-and-replicated-marked-showing-all-categories"></a>
</h4>
</div>
<div class="section level4">
<h4 id="laboratory-abnormalities-with-single-and-replicated-marked-with-study-specific-mlas">
<strong>3. Laboratory Abnormalities with Single and Replicated
Marked with study specific <code>MLAs</code></strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-with-single-and-replicated-marked-with-study-specific-mlas"></a>
</h4>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-abnormalities-by-visit-and-baseline-status-lbt06">
<strong>Laboratory Abnormalities by Visit and Baseline Status
(<code>LBT06</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-by-visit-and-baseline-status-lbt06"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-abnormalities-by-visit-and-baseline-status">
<strong>1. Laboratory Abnormalities by Visit and Baseline
Status</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-by-visit-and-baseline-status"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt06</code></strong> template produces the
standard laboratory abnormalities by visit and baseline status
summary.</li>
</ol>
<div class="sourceCode" id="cb41"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt06</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                                          </span></span>
<span><span class="co">#&gt;     Visit                                                                            </span></span>
<span><span class="co">#&gt;       Abnormality at Visit                A: Drug X      B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;               Baseline Status              (N=134)        (N=134)         (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                               </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                     </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  3/39 (7.7%)     2/40 (5%)      1/37 (2.7%)  </span></span>
<span><span class="co">#&gt;                 Low                       1/4 (25%)         0/2             0/7      </span></span>
<span><span class="co">#&gt;                 Total                    4/43 (9.3%)    2/42 (4.8%)     1/44 (2.3%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 3/42 (7.1%)    3/35 (8.6%)     4/41 (9.8%)  </span></span>
<span><span class="co">#&gt;                 High                         0/1            0/7             0/3      </span></span>
<span><span class="co">#&gt;                 Total                     3/43 (7%)     3/42 (7.1%)     4/44 (9.1%)  </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  5/29 (17.2%)   2/30 (6.7%)     7/45 (15.6%) </span></span>
<span><span class="co">#&gt;                 Low                       1/2 (50%)         0/5             0/7      </span></span>
<span><span class="co">#&gt;                 Total                    6/31 (19.4%)   2/35 (5.7%)     7/52 (13.5%) </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 1/26 (3.8%)    4/33 (12.1%)    4/45 (8.9%)  </span></span>
<span><span class="co">#&gt;                 High                         0/5            0/2         1/7 (14.3%)  </span></span>
<span><span class="co">#&gt;                 Total                    1/31 (3.2%)    4/35 (11.4%)    5/52 (9.6%)  </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  2/34 (5.9%)    3/34 (8.8%)     1/35 (2.9%)  </span></span>
<span><span class="co">#&gt;                 Low                      1/3 (33.3%)        0/0          1/4 (25%)   </span></span>
<span><span class="co">#&gt;                 Total                    3/37 (8.1%)    3/34 (8.8%)     2/39 (5.1%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 5/33 (15.2%)   5/29 (17.2%)    3/34 (8.8%)  </span></span>
<span><span class="co">#&gt;                 High                      1/4 (25%)         0/5             0/5      </span></span>
<span><span class="co">#&gt;                 Total                    6/37 (16.2%)   5/34 (14.7%)    3/39 (7.7%)  </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                   2/40 (5%)     2/39 (5.1%)     1/38 (2.6%)  </span></span>
<span><span class="co">#&gt;                 Low                          0/2         1/4 (25%)          0/5      </span></span>
<span><span class="co">#&gt;                 Total                    2/42 (4.8%)     3/43 (7%)      1/43 (2.3%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 5/36 (13.9%)   1/34 (2.9%)     6/39 (15.4%) </span></span>
<span><span class="co">#&gt;                 High                     1/6 (16.7%)    1/9 (11.1%)         0/4      </span></span>
<span><span class="co">#&gt;                 Total                    6/42 (14.3%)   2/43 (4.7%)      6/43 (14%)  </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  2/35 (5.7%)    6/35 (17.1%)    4/44 (9.1%)  </span></span>
<span><span class="co">#&gt;                 Low                      1/3 (33.3%)     2/8 (25%)          0/3      </span></span>
<span><span class="co">#&gt;                 Total                    3/38 (7.9%)    8/43 (18.6%)    4/47 (8.5%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 4/38 (10.5%)   7/38 (18.4%)    1/41 (2.4%)  </span></span>
<span><span class="co">#&gt;                 High                         0/0            0/5             0/6      </span></span>
<span><span class="co">#&gt;                 Total                    4/38 (10.5%)   7/43 (16.3%)    1/47 (2.1%)  </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                     </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                     </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  4/46 (8.7%)     2/40 (5%)      4/42 (9.5%)  </span></span>
<span><span class="co">#&gt;                 Low                          0/5            0/2             0/2      </span></span>
<span><span class="co">#&gt;                 Total                    4/51 (7.8%)    2/42 (4.8%)     4/44 (9.1%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 6/44 (13.6%)   4/37 (10.8%)    1/35 (2.9%)  </span></span>
<span><span class="co">#&gt;                 High                         0/7         1/5 (20%)          0/9      </span></span>
<span><span class="co">#&gt;                 Total                    6/51 (11.8%)   5/42 (11.9%)    1/44 (2.3%)  </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  4/39 (10.3%)   3/29 (10.3%)    2/33 (6.1%)  </span></span>
<span><span class="co">#&gt;                 Low                      1/3 (33.3%)        0/2             0/3      </span></span>
<span><span class="co">#&gt;                 Total                    5/42 (11.9%)   3/31 (9.7%)     2/36 (5.6%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 2/36 (5.6%)    3/27 (11.1%)    3/27 (11.1%) </span></span>
<span><span class="co">#&gt;                 High                         0/6         1/4 (25%)          0/9      </span></span>
<span><span class="co">#&gt;                 Total                    2/42 (4.8%)    4/31 (12.9%)    3/36 (8.3%)  </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  3/37 (8.1%)     6/46 (13%)     8/44 (18.2%) </span></span>
<span><span class="co">#&gt;                 Low                          0/3            0/5             0/6      </span></span>
<span><span class="co">#&gt;                 Total                    3/40 (7.5%)    6/51 (11.8%)     8/50 (16%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 2/34 (5.9%)    2/44 (4.5%)     1/43 (2.3%)  </span></span>
<span><span class="co">#&gt;                 High                         0/6            0/7             0/7      </span></span>
<span><span class="co">#&gt;                 Total                     2/40 (5%)     2/51 (3.9%)      1/50 (2%)   </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  3/42 (7.1%)    1/36 (2.8%)     4/34 (11.8%) </span></span>
<span><span class="co">#&gt;                 Low                          0/4         1/2 (50%)          0/5      </span></span>
<span><span class="co">#&gt;                 Total                    3/46 (6.5%)    2/38 (5.3%)     4/39 (10.3%) </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 3/40 (7.5%)    1/35 (2.9%)     5/34 (14.7%) </span></span>
<span><span class="co">#&gt;                 High                     1/6 (16.7%)    1/3 (33.3%)         0/5      </span></span>
<span><span class="co">#&gt;                 Total                    4/46 (8.7%)    2/38 (5.3%)     5/39 (12.8%) </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  5/34 (14.7%)   4/38 (10.5%)    5/41 (12.2%) </span></span>
<span><span class="co">#&gt;                 Low                      1/6 (16.7%)        0/4          1/5 (20%)   </span></span>
<span><span class="co">#&gt;                 Total                     6/40 (15%)    4/42 (9.5%)      6/46 (13%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 4/35 (11.4%)   4/35 (11.4%)    3/39 (7.7%)  </span></span>
<span><span class="co">#&gt;                 High                         0/5            0/7         1/7 (14.3%)  </span></span>
<span><span class="co">#&gt;                 Total                     4/40 (10%)    4/42 (9.5%)     4/46 (8.7%)  </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                       </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                     </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  2/38 (5.3%)    3/38 (7.9%)      3/30 (10%)  </span></span>
<span><span class="co">#&gt;                 Low                      1/7 (14.3%)     1/4 (25%)       1/4 (25%)   </span></span>
<span><span class="co">#&gt;                 Total                    3/45 (6.7%)    4/42 (9.5%)     4/34 (11.8%) </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 2/38 (5.3%)    3/37 (8.1%)     1/30 (3.3%)  </span></span>
<span><span class="co">#&gt;                 High                     2/7 (28.6%)     1/5 (20%)       1/4 (25%)   </span></span>
<span><span class="co">#&gt;                 Total                    4/45 (8.9%)    4/42 (9.5%)     2/34 (5.9%)  </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  2/36 (5.6%)    5/45 (11.1%)    5/43 (11.6%) </span></span>
<span><span class="co">#&gt;                 Low                       1/4 (25%)         0/4         1/6 (16.7%)  </span></span>
<span><span class="co">#&gt;                 Total                    3/40 (7.5%)    5/49 (10.2%)    6/49 (12.2%) </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 7/39 (17.9%)   4/44 (9.1%)     5/46 (10.9%) </span></span>
<span><span class="co">#&gt;                 High                         0/1            0/5             0/3      </span></span>
<span><span class="co">#&gt;                 Total                    7/40 (17.5%)   4/49 (8.2%)     5/49 (10.2%) </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  7/43 (16.3%)    4/40 (10%)     2/38 (5.3%)  </span></span>
<span><span class="co">#&gt;                 Low                          0/5            0/10         2/4 (50%)   </span></span>
<span><span class="co">#&gt;                 Total                    7/48 (14.6%)    4/50 (8%)      4/42 (9.5%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 2/41 (4.9%)    5/48 (10.4%)    5/36 (13.9%) </span></span>
<span><span class="co">#&gt;                 High                         0/7            0/2             0/6      </span></span>
<span><span class="co">#&gt;                 Total                    2/48 (4.2%)     5/50 (10%)     5/42 (11.9%) </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  2/29 (6.9%)    7/43 (16.3%)    4/46 (8.7%)  </span></span>
<span><span class="co">#&gt;                 Low                          0/5            0/10            0/2      </span></span>
<span><span class="co">#&gt;                 Total                    2/34 (5.9%)    7/53 (13.2%)    4/48 (8.3%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 6/29 (20.7%)   4/49 (8.2%)     3/44 (6.8%)  </span></span>
<span><span class="co">#&gt;                 High                         0/5         1/4 (25%)       1/4 (25%)   </span></span>
<span><span class="co">#&gt;                 Total                    6/34 (17.6%)   5/53 (9.4%)     4/48 (8.3%)  </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  4/41 (9.8%)    6/39 (15.4%)    5/38 (13.2%) </span></span>
<span><span class="co">#&gt;                 Low                          0/2            0/5             0/2      </span></span>
<span><span class="co">#&gt;                 Total                    4/43 (9.3%)    6/44 (13.6%)    5/40 (12.5%) </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 3/37 (8.1%)    5/39 (12.8%)    4/38 (10.5%) </span></span>
<span><span class="co">#&gt;                 High                         0/6            0/5          1/2 (50%)   </span></span>
<span><span class="co">#&gt;                 Total                     3/43 (7%)     5/44 (11.4%)    5/40 (12.5%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline-lbt07">
<strong>Laboratory Test Results with Highest <code>NCI CTCAE</code>
Grade Post-Baseline (<code>LBT07</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline-lbt07"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline">
<strong>1. Laboratory Test Results with Highest
<code>NCI CTCAE</code> Grade Post-Baseline</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt07</code></strong> template produces the
standard laboratory test results with highest <code>NCI CTCAE</code>
grade post-baseline summary.<br>
</li>
<li>The laboratory tests and grades in this template is currently
data-driven. The standard metadata for possible lab tests and
corresponding <code>NCI CTCAE</code> grade will be incorporated in
future release.</li>
</ol>
<div class="sourceCode" id="cb42"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt07</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                                          </span></span>
<span><span class="co">#&gt;     Direction of Abnormality                 A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;               Highest NCI CTCAE Grade         (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement (n)      134          134            132      </span></span>
<span><span class="co">#&gt;     LOW                                                                              </span></span>
<span><span class="co">#&gt;               1                              14 (10.4%)   15 (11.2%)     10 (7.6%)   </span></span>
<span><span class="co">#&gt;               2                              13 (9.7%)    18 (13.4%)     11 (8.3%)   </span></span>
<span><span class="co">#&gt;               3                              20 (14.9%)   12 (9.0%)      10 (7.6%)   </span></span>
<span><span class="co">#&gt;               4                               7 (5.2%)     8 (6.0%)      10 (7.6%)   </span></span>
<span><span class="co">#&gt;               Any                            54 (40.3%)   53 (39.6%)     41 (31.1%)  </span></span>
<span><span class="co">#&gt;     HIGH                                                                             </span></span>
<span><span class="co">#&gt;               1                              18 (13.4%)   16 (11.9%)     18 (13.6%)  </span></span>
<span><span class="co">#&gt;               2                              15 (11.2%)   13 (9.7%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;               3                              10 (7.5%)    16 (11.9%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;               4                              12 (9.0%)    11 (8.2%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;               Any                            55 (41.0%)   56 (41.8%)     62 (47.0%)  </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement (n)            134          134            132      </span></span>
<span><span class="co">#&gt;     LOW                                                                              </span></span>
<span><span class="co">#&gt;               1                              16 (11.9%)   19 (14.2%)     15 (11.4%)  </span></span>
<span><span class="co">#&gt;               2                              21 (15.7%)   13 (9.7%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;               3                              12 (9.0%)     9 (6.7%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;               4                              11 (8.2%)     7 (5.2%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;               Any                            60 (44.8%)   48 (35.8%)     54 (40.9%)  </span></span>
<span><span class="co">#&gt;     HIGH                                                                             </span></span>
<span><span class="co">#&gt;               1                              17 (12.7%)   15 (11.2%)      9 (6.8%)   </span></span>
<span><span class="co">#&gt;               2                              15 (11.2%)   16 (11.9%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;               3                              16 (11.9%)   12 (9.0%)      14 (10.6%)  </span></span>
<span><span class="co">#&gt;               4                              12 (9.0%)    12 (9.0%)      10 (7.6%)   </span></span>
<span><span class="co">#&gt;               Any                            60 (44.8%)   55 (41.0%)     46 (34.8%)  </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement (n)              134          134            132      </span></span>
<span><span class="co">#&gt;     LOW                                                                              </span></span>
<span><span class="co">#&gt;               1                              17 (12.7%)   23 (17.2%)     17 (12.9%)  </span></span>
<span><span class="co">#&gt;               2                              12 (9.0%)    15 (11.2%)     14 (10.6%)  </span></span>
<span><span class="co">#&gt;               3                              15 (11.2%)   11 (8.2%)      14 (10.6%)  </span></span>
<span><span class="co">#&gt;               4                              10 (7.5%)    16 (11.9%)     10 (7.6%)   </span></span>
<span><span class="co">#&gt;               Any                            54 (40.3%)   65 (48.5%)     55 (41.7%)  </span></span>
<span><span class="co">#&gt;     HIGH                                                                             </span></span>
<span><span class="co">#&gt;               1                              25 (18.7%)   14 (10.4%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;               2                              14 (10.4%)   20 (14.9%)     16 (12.1%)  </span></span>
<span><span class="co">#&gt;               3                              12 (9.0%)    13 (9.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;               4                              11 (8.2%)    13 (9.7%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;               Any                            62 (46.3%)   60 (44.8%)     50 (37.9%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-lbt14">
<strong>Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (<code>LBT14</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-lbt14"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high">
<strong>1. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (High)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high"></a>
</h4>
<p>To produce the standard laboratory test results shift table - highest
<code>NCI-CTCAE</code> grade post-baseline by baseline
<code>NCI-CTCAE</code> grade summary for high abnormalities, use the
<strong><code>lbt14</code></strong> template and set the parameter
<em><code>direction</code></em> to <code>high</code>.</p>
<div class="sourceCode" id="cb43"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt14</span>, <span class="va">syn_data</span>, direction <span class="op">=</span> <span class="st">"high"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                                             </span></span>
<span><span class="co">#&gt;         Baseline NCI-CTCAE Grade                A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                 Post-baseline NCI-CTCAE Grade    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                                  </span></span>
<span><span class="co">#&gt;         Not High                                   121          118            118      </span></span>
<span><span class="co">#&gt;                 Not High                        72 (53.7%)   70 (52.2%)     59 (44.7%)  </span></span>
<span><span class="co">#&gt;                 1                               16 (11.9%)   13 (9.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;                 2                               13 (9.7%)    12 (9.0%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;                 3                                9 (6.7%)    14 (10.4%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;                 4                               11 (8.2%)     9 (6.7%)      12 (9.1%)   </span></span>
<span><span class="co">#&gt;         1                                           4            4              3       </span></span>
<span><span class="co">#&gt;                 Not High                         1 (0.7%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;         2                                           4            4              4       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     3 (2.2%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;         3                                           2            5              5       </span></span>
<span><span class="co">#&gt;                 Not High                         2 (1.5%)     2 (1.5%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         4                                           3            3              2       </span></span>
<span><span class="co">#&gt;                 Not High                         1 (0.7%)     2 (1.5%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 3                                1 (0.7%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                        </span></span>
<span><span class="co">#&gt;         Not High                                   115          115            114      </span></span>
<span><span class="co">#&gt;                 Not High                        60 (44.8%)   68 (50.7%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;                 1                               17 (12.7%)   13 (9.7%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;                 2                               12 (9.0%)    14 (10.4%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 3                               16 (11.9%)   10 (7.5%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 4                               10 (7.5%)    10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;         1                                           5            5              5       </span></span>
<span><span class="co">#&gt;                 Not High                         4 (3.0%)     3 (2.2%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;                 2                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;         2                                           6            5              5       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 2                                2 (1.5%)        0              0       </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;         3                                           2            3              5       </span></span>
<span><span class="co">#&gt;                 Not High                         2 (1.5%)     1 (0.7%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 3                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;         4                                           6            6              3       </span></span>
<span><span class="co">#&gt;                 Not High                         5 (3.7%)     4 (3.0%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                          </span></span>
<span><span class="co">#&gt;         Not High                                   119          123            119      </span></span>
<span><span class="co">#&gt;                 Not High                        61 (45.5%)   69 (51.5%)     74 (56.1%)  </span></span>
<span><span class="co">#&gt;                 1                               24 (17.9%)   12 (9.0%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 2                               13 (9.7%)    20 (14.9%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;                 3                               11 (8.2%)    11 (8.2%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                 4                               10 (7.5%)    11 (8.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;         1                                           2            4              6       </span></span>
<span><span class="co">#&gt;                 Not High                         2 (1.5%)     2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;                 2                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;         2                                           4            4              3       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;         3                                           5            2              2       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;         4                                           4            1              2       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0           1 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low">
<strong>2. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (Low)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low"></a>
</h4>
<p>To produce the standard laboratory test results shift table - highest
<code>NCI-CTCAE</code> grade post-baseline by baseline
<code>NCI-CTCAE</code> grade summary for high abnormalities, use the
<strong><code>lbt14</code></strong> template and the parameter
<code>direction</code> is <code>low</code> by default.</p>
<div class="sourceCode" id="cb44"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt14</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                                             </span></span>
<span><span class="co">#&gt;         Baseline NCI-CTCAE Grade                A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                 Post-baseline NCI-CTCAE Grade    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                                  </span></span>
<span><span class="co">#&gt;         Not Low                                    124          122            117      </span></span>
<span><span class="co">#&gt;                 Not Low                         74 (55.2%)   76 (56.7%)     80 (60.6%)  </span></span>
<span><span class="co">#&gt;                 1                               13 (9.7%)    12 (9.0%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;                 2                               13 (9.7%)    16 (11.9%)     11 (8.3%)   </span></span>
<span><span class="co">#&gt;                 3                               17 (12.7%)   11 (8.2%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;                 4                                7 (5.2%)     7 (5.2%)       8 (6.1%)   </span></span>
<span><span class="co">#&gt;         1                                           3            6              7       </span></span>
<span><span class="co">#&gt;                 Not Low                             0         2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 3                                2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0           2 (1.5%)   </span></span>
<span><span class="co">#&gt;         2                                           2            1              4       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)        0           3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         3                                           2            3              4       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)     2 (1.5%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;         4                                           3            2              0       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 3                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 4                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                        </span></span>
<span><span class="co">#&gt;         Not Low                                    122          125            120      </span></span>
<span><span class="co">#&gt;                 Not Low                         67 (50.0%)   81 (60.4%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;                 1                               14 (10.4%)   17 (12.7%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 2                               20 (14.9%)   11 (8.2%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                 3                               12 (9.0%)     9 (6.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;                 4                                9 (6.7%)     7 (5.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;         1                                           2            5              5       </span></span>
<span><span class="co">#&gt;                 Not Low                             0         3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;         2                                           5            1              1       </span></span>
<span><span class="co">#&gt;                 Not Low                          3 (2.2%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 1                                2 (1.5%)        0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;         3                                           2            2              1       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         4                                           3            1              5       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)     1 (0.7%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 1                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                          </span></span>
<span><span class="co">#&gt;         Not Low                                    120          119            120      </span></span>
<span><span class="co">#&gt;                 Not Low                         69 (51.5%)   58 (43.3%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;                 1                               16 (11.9%)   20 (14.9%)     16 (12.1%)  </span></span>
<span><span class="co">#&gt;                 2                               12 (9.0%)    14 (10.4%)     14 (10.6%)  </span></span>
<span><span class="co">#&gt;                 3                               14 (10.4%)   11 (8.2%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 4                                9 (6.7%)    16 (11.9%)      7 (5.3%)   </span></span>
<span><span class="co">#&gt;         1                                           8            8              3       </span></span>
<span><span class="co">#&gt;                 Not Low                          7 (5.2%)     4 (3.0%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)     3 (2.2%)          0       </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         2                                           2            1              2       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;         3                                           3            3              4       </span></span>
<span><span class="co">#&gt;                 Not Low                          1 (0.7%)     3 (2.2%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;                 1                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         4                                           1            3              3       </span></span>
<span><span class="co">#&gt;                 Not Low                          1 (0.7%)     3 (2.2%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                   0            0           1 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high-without-patients-with-missing-baseline">
<strong>3. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (High) Without Patients with Missing
Baseline</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high-without-patients-with-missing-baseline"></a>
</h4>
<p>To exclude patients with missing baseline grade, set the parameter
<code>gr_missing</code> to <code>excl</code>.</p>
<div class="sourceCode" id="cb45"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt14</span>, <span class="va">syn_data</span>, direction <span class="op">=</span> <span class="st">"high"</span>, gr_missing <span class="op">=</span> <span class="st">"excl"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                                             </span></span>
<span><span class="co">#&gt;         Baseline NCI-CTCAE Grade                A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                 Post-baseline NCI-CTCAE Grade    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                                  </span></span>
<span><span class="co">#&gt;         Not High                                   121          118            118      </span></span>
<span><span class="co">#&gt;                 Not High                        72 (53.7%)   70 (52.2%)     59 (44.7%)  </span></span>
<span><span class="co">#&gt;                 1                               16 (11.9%)   13 (9.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;                 2                               13 (9.7%)    12 (9.0%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;                 3                                9 (6.7%)    14 (10.4%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;                 4                               11 (8.2%)     9 (6.7%)      12 (9.1%)   </span></span>
<span><span class="co">#&gt;         1                                           4            4              3       </span></span>
<span><span class="co">#&gt;                 Not High                         1 (0.7%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;         2                                           4            4              4       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     3 (2.2%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;         3                                           2            5              5       </span></span>
<span><span class="co">#&gt;                 Not High                         2 (1.5%)     2 (1.5%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         4                                           3            3              2       </span></span>
<span><span class="co">#&gt;                 Not High                         1 (0.7%)     2 (1.5%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 3                                1 (0.7%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                        </span></span>
<span><span class="co">#&gt;         Not High                                   115          115            114      </span></span>
<span><span class="co">#&gt;                 Not High                        60 (44.8%)   68 (50.7%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;                 1                               17 (12.7%)   13 (9.7%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;                 2                               12 (9.0%)    14 (10.4%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 3                               16 (11.9%)   10 (7.5%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 4                               10 (7.5%)    10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;         1                                           5            5              5       </span></span>
<span><span class="co">#&gt;                 Not High                         4 (3.0%)     3 (2.2%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;                 2                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;         2                                           6            5              5       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 2                                2 (1.5%)        0              0       </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;         3                                           2            3              5       </span></span>
<span><span class="co">#&gt;                 Not High                         2 (1.5%)     1 (0.7%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 3                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;         4                                           6            6              3       </span></span>
<span><span class="co">#&gt;                 Not High                         5 (3.7%)     4 (3.0%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                          </span></span>
<span><span class="co">#&gt;         Not High                                   119          123            119      </span></span>
<span><span class="co">#&gt;                 Not High                        61 (45.5%)   69 (51.5%)     74 (56.1%)  </span></span>
<span><span class="co">#&gt;                 1                               24 (17.9%)   12 (9.0%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 2                               13 (9.7%)    20 (14.9%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;                 3                               11 (8.2%)    11 (8.2%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                 4                               10 (7.5%)    11 (8.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;         1                                           2            4              6       </span></span>
<span><span class="co">#&gt;                 Not High                         2 (1.5%)     2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;                 2                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;         2                                           4            4              3       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;         3                                           5            2              2       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;         4                                           4            1              2       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0           1 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low-with-missing-baseline-considered-as-grade-0">
<strong>4. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (Low) with Missing Baseline Considered as
Grade 0</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low-with-missing-baseline-considered-as-grade-0"></a>
</h4>
<p>To count patients with missing baseline grade as grade 0, set the
parameter <code>gr_missing</code> to <code>gr_0</code>.</p>
<div class="sourceCode" id="cb46"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt14</span>, <span class="va">syn_data</span>, gr_missing <span class="op">=</span> <span class="st">"gr_0"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                                             </span></span>
<span><span class="co">#&gt;         Baseline NCI-CTCAE Grade                A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                 Post-baseline NCI-CTCAE Grade    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                                  </span></span>
<span><span class="co">#&gt;         1                                           3            6              7       </span></span>
<span><span class="co">#&gt;                 Not Low                             0         2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 3                                2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0           2 (1.5%)   </span></span>
<span><span class="co">#&gt;         2                                           2            1              4       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)        0           3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         3                                           2            3              4       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)     2 (1.5%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;         4                                           3            2              0       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 3                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 4                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;         Not Low                                    124          122            117      </span></span>
<span><span class="co">#&gt;                 Not Low                         74 (55.2%)   76 (56.7%)     80 (60.6%)  </span></span>
<span><span class="co">#&gt;                 1                               13 (9.7%)    12 (9.0%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;                 2                               13 (9.7%)    16 (11.9%)     11 (8.3%)   </span></span>
<span><span class="co">#&gt;                 3                               17 (12.7%)   11 (8.2%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;                 4                                7 (5.2%)     7 (5.2%)       8 (6.1%)   </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                        </span></span>
<span><span class="co">#&gt;         1                                           2            5              5       </span></span>
<span><span class="co">#&gt;                 Not Low                             0         3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;         2                                           5            1              1       </span></span>
<span><span class="co">#&gt;                 Not Low                          3 (2.2%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 1                                2 (1.5%)        0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;         3                                           2            2              1       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         4                                           3            1              5       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)     1 (0.7%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 1                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         Not Low                                    122          125            120      </span></span>
<span><span class="co">#&gt;                 Not Low                         67 (50.0%)   81 (60.4%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;                 1                               14 (10.4%)   17 (12.7%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 2                               20 (14.9%)   11 (8.2%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                 3                               12 (9.0%)     9 (6.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;                 4                                9 (6.7%)     7 (5.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                          </span></span>
<span><span class="co">#&gt;         1                                           8            8              3       </span></span>
<span><span class="co">#&gt;                 Not Low                          7 (5.2%)     4 (3.0%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)     3 (2.2%)          0       </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         2                                           2            1              2       </span></span>
<span><span class="co">#&gt;                 Not Low                          2 (1.5%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;         3                                           3            3              4       </span></span>
<span><span class="co">#&gt;                 Not Low                          1 (0.7%)     3 (2.2%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;                 1                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         4                                           1            3              3       </span></span>
<span><span class="co">#&gt;                 Not Low                          1 (0.7%)     3 (2.2%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         Not Low                                    120          119            120      </span></span>
<span><span class="co">#&gt;                 Not Low                         69 (51.5%)   58 (43.3%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;                 1                               16 (11.9%)   20 (14.9%)     16 (12.1%)  </span></span>
<span><span class="co">#&gt;                 2                               12 (9.0%)    14 (10.4%)     14 (10.6%)  </span></span>
<span><span class="co">#&gt;                 3                               14 (10.4%)   11 (8.2%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 4                                9 (6.7%)    16 (11.9%)      7 (5.3%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-with-fill-in-of-grades">
<strong>4. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (with fill in of grades)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-with-fill-in-of-grades"></a>
</h4>
<p>To display all possible grades even if they do not occur in the data,
set the parameter <code>prune_0</code> to <code>FALSE</code>.</p>
<div class="sourceCode" id="cb47"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt14</span>, <span class="va">syn_data</span>, direction <span class="op">=</span> <span class="st">"high"</span>, prune_0 <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                                             </span></span>
<span><span class="co">#&gt;         Baseline NCI-CTCAE Grade                A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                 Post-baseline NCI-CTCAE Grade    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                                  </span></span>
<span><span class="co">#&gt;         Not High                                   121          118            118      </span></span>
<span><span class="co">#&gt;                 Not High                        72 (53.7%)   70 (52.2%)     59 (44.7%)  </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                               16 (11.9%)   13 (9.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;                 2                               13 (9.7%)    12 (9.0%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;                 3                                9 (6.7%)    14 (10.4%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;                 4                               11 (8.2%)     9 (6.7%)      12 (9.1%)   </span></span>
<span><span class="co">#&gt;         1                                           4            4              3       </span></span>
<span><span class="co">#&gt;                 Not High                         1 (0.7%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;         2                                           4            4              4       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     3 (2.2%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0              0       </span></span>
<span><span class="co">#&gt;         3                                           2            5              5       </span></span>
<span><span class="co">#&gt;                 Not High                         2 (1.5%)     2 (1.5%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 2                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;         4                                           3            3              2       </span></span>
<span><span class="co">#&gt;                 Not High                         1 (0.7%)     2 (1.5%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 3                                1 (0.7%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0              0       </span></span>
<span><span class="co">#&gt;         Missing                                     0            0              0       </span></span>
<span><span class="co">#&gt;                 Not High                            0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                        </span></span>
<span><span class="co">#&gt;         Not High                                   115          115            114      </span></span>
<span><span class="co">#&gt;                 Not High                        60 (44.8%)   68 (50.7%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                               17 (12.7%)   13 (9.7%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;                 2                               12 (9.0%)    14 (10.4%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 3                               16 (11.9%)   10 (7.5%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 4                               10 (7.5%)    10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;         1                                           5            5              5       </span></span>
<span><span class="co">#&gt;                 Not High                         4 (3.0%)     3 (2.2%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;         2                                           6            5              5       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 2                                2 (1.5%)        0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;         3                                           2            3              5       </span></span>
<span><span class="co">#&gt;                 Not High                         2 (1.5%)     1 (0.7%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;         4                                           6            6              3       </span></span>
<span><span class="co">#&gt;                 Not High                         5 (3.7%)     4 (3.0%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0              0       </span></span>
<span><span class="co">#&gt;         Missing                                     0            0              0       </span></span>
<span><span class="co">#&gt;                 Not High                            0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                          </span></span>
<span><span class="co">#&gt;         Not High                                   119          123            119      </span></span>
<span><span class="co">#&gt;                 Not High                        61 (45.5%)   69 (51.5%)     74 (56.1%)  </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                               24 (17.9%)   12 (9.0%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;                 2                               13 (9.7%)    20 (14.9%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;                 3                               11 (8.2%)    11 (8.2%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                 4                               10 (7.5%)    11 (8.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;         1                                           2            4              6       </span></span>
<span><span class="co">#&gt;                 Not High                         2 (1.5%)     2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 4                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;         2                                           4            4              3       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 4                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;         3                                           5            2              2       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0              0       </span></span>
<span><span class="co">#&gt;         4                                           4            1              2       </span></span>
<span><span class="co">#&gt;                 Not High                         3 (2.2%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 2                                1 (0.7%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;                 3                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0              0       </span></span>
<span><span class="co">#&gt;         Missing                                     0            0              0       </span></span>
<span><span class="co">#&gt;                 Not High                            0            0              0       </span></span>
<span><span class="co">#&gt;                 1                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 2                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 3                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 4                                   0            0              0       </span></span>
<span><span class="co">#&gt;                 Missing                             0            0              0</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="medical-history-mht01">
<strong>Medical History (<code>MHT01</code>)</strong><a class="anchor" aria-label="anchor" href="#medical-history-mht01"></a>
</h3>
<div class="section level4">
<h4 id="medical-history">
<strong>1. Medical History</strong><a class="anchor" aria-label="anchor" href="#medical-history"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>mht01</code></strong> template displays medical
conditions by MedDRA system organ class and Preferred Name by
default.<br>
</li>
<li>The default treatment variable is <code>ADSL.ARM</code>.<br>
</li>
<li>The user is expected to use filter to subset medical conditions
prior to or on entering study.<br>
</li>
<li>By default, the template produces the overall ‘total number of
conditions’ as well as the ‘total number of conditions’ per body system
after the summary of patients.<br>
5）This template currently does not support sorting MedDRA system organ
class and preferred names by order of frequency.</li>
</ol>
<div class="sourceCode" id="cb48"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">mht01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                 A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                                    (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one condition     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of conditions                                   609           622            703      </span></span>
<span><span class="co">#&gt;   cl A                                                                                               </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 132           130            160      </span></span>
<span><span class="co">#&gt;     trm A_1/2                                              50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;     trm A_2/2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl B                                                                                               </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   96 (71.6%)    89 (66.4%)      97 (73.5%)  </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 185           198            205      </span></span>
<span><span class="co">#&gt;     trm B_3/3                                              48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     trm B_2/3                                              49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;     trm B_1/3                                              47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C                                                                                               </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   67 (50.0%)    75 (56.0%)      79 (59.8%)  </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 103           116            129      </span></span>
<span><span class="co">#&gt;     trm C_2/2                                              35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     trm C_1/2                                              43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl D                                                                                               </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   96 (71.6%)    90 (67.2%)      98 (74.2%)  </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 189           178            209      </span></span>
<span><span class="co">#&gt;     trm D_3/3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     trm D_1/3                                              50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     trm D_2/3                                              48 (35.8%)    42 (31.3%)      50 (37.9%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="medical-history-showing-additional-column-all-patients">
<strong>2. Medical History showing additional column ‘All
Patients’</strong><a class="anchor" aria-label="anchor" href="#medical-history-showing-additional-column-all-patients"></a>
</h4>
<div class="sourceCode" id="cb49"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">mht01</span>, <span class="va">syn_data</span>, lbl_overall <span class="op">=</span> <span class="st">"All Patients"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                 A: Drug X    B: Placebo    C: Combination   All Patients</span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                                    (N=134)       (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one condition     122 (91.0%)   123 (91.8%)    120 (90.9%)     365 (91.2%) </span></span>
<span><span class="co">#&gt;   Total number of conditions                                   609           622            703             1934    </span></span>
<span><span class="co">#&gt;   cl A                                                                                                              </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   78 (58.2%)    75 (56.0%)      89 (67.4%)     242 (60.5%) </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 132           130            160             422     </span></span>
<span><span class="co">#&gt;     trm A_1/2                                              50 (37.3%)    45 (33.6%)      63 (47.7%)     158 (39.5%) </span></span>
<span><span class="co">#&gt;     trm A_2/2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)     146 (36.5%) </span></span>
<span><span class="co">#&gt;   cl B                                                                                                              </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   96 (71.6%)    89 (66.4%)      97 (73.5%)     282 (70.5%) </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 185           198            205             588     </span></span>
<span><span class="co">#&gt;     trm B_3/3                                              48 (35.8%)    54 (40.3%)      51 (38.6%)     153 (38.2%) </span></span>
<span><span class="co">#&gt;     trm B_2/3                                              49 (36.6%)    44 (32.8%)      52 (39.4%)     145 (36.2%) </span></span>
<span><span class="co">#&gt;     trm B_1/3                                              47 (35.1%)    49 (36.6%)      43 (32.6%)     139 (34.8%) </span></span>
<span><span class="co">#&gt;   cl C                                                                                                              </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   67 (50.0%)    75 (56.0%)      79 (59.8%)     221 (55.2%) </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 103           116            129             348     </span></span>
<span><span class="co">#&gt;     trm C_2/2                                              35 (26.1%)    48 (35.8%)      55 (41.7%)     138 (34.5%) </span></span>
<span><span class="co">#&gt;     trm C_1/2                                              43 (32.1%)    46 (34.3%)      43 (32.6%)     132 (33.0%) </span></span>
<span><span class="co">#&gt;   cl D                                                                                                              </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   96 (71.6%)    90 (67.2%)      98 (74.2%)     284 (71.0%) </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 189           178            209             576     </span></span>
<span><span class="co">#&gt;     trm D_3/3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)     162 (40.5%) </span></span>
<span><span class="co">#&gt;     trm D_1/3                                              50 (37.3%)    42 (31.3%)      51 (38.6%)     143 (35.8%) </span></span>
<span><span class="co">#&gt;     trm D_2/3                                              48 (35.8%)    42 (31.3%)      50 (37.9%)     140 (35.0%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="vital-signs-vst01">
<strong>Vital Signs (<code>VST01</code>)</strong><a class="anchor" aria-label="anchor" href="#vital-signs-vst01"></a>
</h3>
<div class="section level4">
<h4 id="vital-sign-results-and-change-from-baseline-by-visit">
<strong>1. Vital Sign Results and Change from Baseline by
Visit</strong><a class="anchor" aria-label="anchor" href="#vital-sign-results-and-change-from-baseline-by-visit"></a>
</h4>
<div class="sourceCode" id="cb50"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">t_vs_chg</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">vst01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/utils/head.html" class="external-link">head</a></span><span class="op">(</span><span class="va">t_vs_chg</span>, <span class="fl">20</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         A: Drug X                         B: Placebo                       C: Combination         </span></span>
<span><span class="co">#&gt;                                                Change from                        Change from                        Change from  </span></span>
<span><span class="co">#&gt;                              Value at Visit      Baseline      Value at Visit      Baseline       Value at Visit      Baseline    </span></span>
<span><span class="co">#&gt;                                 (N=134)          (N=134)          (N=134)           (N=134)          (N=132)           (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Diastolic Blood Pressure                                                                                                        </span></span>
<span><span class="co">#&gt;     SCREENING                                                                                                                     </span></span>
<span><span class="co">#&gt;       n                           134               0               134                0               132                0       </span></span>
<span><span class="co">#&gt;       Mean (SD)              49.968 (7.197)      NE (NE)       50.753 (8.429)       NE (NE)       50.192 (7.627)       NE (NE)    </span></span>
<span><span class="co">#&gt;       Median                     49.706             NE             50.087             NE              49.641             NE       </span></span>
<span><span class="co">#&gt;       Min - Max              31.69 - 71.19       NE - NE       29.26 - 69.21        NE - NE       26.89 - 69.98        NE - NE    </span></span>
<span><span class="co">#&gt;     BASELINE                                                                                                                      </span></span>
<span><span class="co">#&gt;       n                           134                               134                                132                        </span></span>
<span><span class="co">#&gt;       Mean (SD)              48.602 (7.962)                    50.442 (7.948)                     51.107 (7.790)                  </span></span>
<span><span class="co">#&gt;       Median                     48.418                            50.179                             50.804                      </span></span>
<span><span class="co">#&gt;       Min - Max              27.71 - 64.64                     21.68 - 67.51                      29.75 - 71.40                   </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                  </span></span>
<span><span class="co">#&gt;       n                           134              134              134               134              132               132      </span></span>
<span><span class="co">#&gt;       Mean (SD)              50.260 (7.514)   1.658 (10.774)   49.674 (7.743)   -0.767 (10.947)   48.855 (7.888)   -2.251 (10.380)</span></span>
<span><span class="co">#&gt;       Median                     50.088           0.607            49.747           -1.114            47.677           -2.229     </span></span>
<span><span class="co">#&gt;       Min - Max              33.04 - 68.98    -20.37 - 29.94   33.71 - 66.49    -25.80 - 28.37    30.39 - 66.99    -22.06 - 22.44 </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                 </span></span>
<span><span class="co">#&gt;       n                           134              134              134               134              132               132      </span></span>
<span><span class="co">#&gt;       Mean (SD)              50.836 (7.850)   2.234 (11.752)   49.718 (8.445)   -0.724 (12.444)   49.981 (8.338)   -1.126 (11.639)</span></span>
<span><span class="co">#&gt;       Median                     51.437           3.126            50.227           -0.709            51.007           -2.271</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="vital-signs-abnormalities-regardless-of-abnormality-at-baseline-vst02_1">
<strong>Vital Signs Abnormalities (Regardless of Abnormality at
Baseline) (<code>VST02_1</code>)</strong><a class="anchor" aria-label="anchor" href="#vital-signs-abnormalities-regardless-of-abnormality-at-baseline-vst02_1"></a>
</h3>
<div class="section level4">
<h4 id="vital-sign-abnormalities-regardless-of-abnormality-at-baseline">
<strong>1. Vital Sign Abnormalities (Regardless of Abnormality at
Baseline)</strong><a class="anchor" aria-label="anchor" href="#vital-sign-abnormalities-regardless-of-abnormality-at-baseline"></a>
</h4>
<div class="sourceCode" id="cb51"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">vst02_1</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Assessment                   A: Drug X        B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;    Abnormality                  (N=134)          (N=134)          (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Diastolic Blood Pressure                                                   </span></span>
<span><span class="co">#&gt;     Low                      69/134 (51.5%)   73/134 (54.5%)   67/132 (50.8%)</span></span>
<span><span class="co">#&gt;     High                     76/134 (56.7%)    67/134 (50%)    65/132 (49.2%)</span></span>
<span><span class="co">#&gt;   Pulse Rate                                                                 </span></span>
<span><span class="co">#&gt;     Low                       75/134 (56%)     67/134 (50%)    69/132 (52.3%)</span></span>
<span><span class="co">#&gt;     High                      67/134 (50%)    74/134 (55.2%)   53/132 (40.2%)</span></span>
<span><span class="co">#&gt;   Respiratory Rate                                                           </span></span>
<span><span class="co">#&gt;     Low                      70/134 (52.2%)   72/134 (53.7%)   64/132 (48.5%)</span></span>
<span><span class="co">#&gt;     High                      75/134 (56%)    65/134 (48.5%)   71/132 (53.8%)</span></span>
<span><span class="co">#&gt;   Systolic Blood Pressure                                                    </span></span>
<span><span class="co">#&gt;     Low                       71/134 (53%)    69/134 (51.5%)    70/132 (53%) </span></span>
<span><span class="co">#&gt;     High                     78/134 (58.2%)   62/134 (46.3%)   64/132 (48.5%)</span></span>
<span><span class="co">#&gt;   Temperature                                                                </span></span>
<span><span class="co">#&gt;     Low                      66/134 (49.3%)   68/134 (50.7%)   81/132 (61.4%)</span></span>
<span><span class="co">#&gt;     High                      67/134 (50%)    66/134 (49.3%)   69/132 (52.3%)</span></span>
<span><span class="co">#&gt;   Weight                                                                     </span></span>
<span><span class="co">#&gt;     Low                      73/134 (54.5%)    71/134 (53%)    76/132 (57.6%)</span></span>
<span><span class="co">#&gt;     High                     69/134 (51.5%)   74/134 (55.2%)   74/132 (56.1%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="vital-signs-abnormalities-among-subject-without-abnormality-at-baseline-vst02_2">
<strong>Vital Signs Abnormalities (Among Subject Without Abnormality
at Baseline) (<code>VST02_2</code>)</strong><a class="anchor" aria-label="anchor" href="#vital-signs-abnormalities-among-subject-without-abnormality-at-baseline-vst02_2"></a>
</h3>
<div class="section level4">
<h4 id="vital-sign-abnormalities-among-subject-without-abnormality-at-baseline">
<strong>1. Vital Sign Abnormalities (Among Subject Without
Abnormality at Baseline)</strong><a class="anchor" aria-label="anchor" href="#vital-sign-abnormalities-among-subject-without-abnormality-at-baseline"></a>
</h4>
<div class="sourceCode" id="cb52"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">vst02_2</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Assessment                   A: Drug X        B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;    Abnormality                  (N=134)          (N=134)          (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Diastolic Blood Pressure                                                   </span></span>
<span><span class="co">#&gt;     Low                      55/120 (45.8%)   60/121 (49.6%)   53/118 (44.9%)</span></span>
<span><span class="co">#&gt;     High                     55/113 (48.7%)   56/123 (45.5%)   52/119 (43.7%)</span></span>
<span><span class="co">#&gt;   Pulse Rate                                                                 </span></span>
<span><span class="co">#&gt;     Low                      66/125 (52.8%)   54/121 (44.6%)   55/118 (46.6%)</span></span>
<span><span class="co">#&gt;     High                     52/119 (43.7%)   59/119 (49.6%)   38/117 (32.5%)</span></span>
<span><span class="co">#&gt;   Respiratory Rate                                                           </span></span>
<span><span class="co">#&gt;     Low                       59/123 (48%)    56/118 (47.5%)   50/118 (42.4%)</span></span>
<span><span class="co">#&gt;     High                     65/124 (52.4%)   58/127 (45.7%)   57/118 (48.3%)</span></span>
<span><span class="co">#&gt;   Systolic Blood Pressure                                                    </span></span>
<span><span class="co">#&gt;     Low                      53/116 (45.7%)   55/120 (45.8%)   58/120 (48.3%)</span></span>
<span><span class="co">#&gt;     High                     65/121 (53.7%)   53/125 (42.4%)   56/124 (45.2%)</span></span>
<span><span class="co">#&gt;   Temperature                                                                </span></span>
<span><span class="co">#&gt;     Low                      51/119 (42.9%)   53/119 (44.5%)   64/115 (55.7%)</span></span>
<span><span class="co">#&gt;     High                     61/128 (47.7%)   53/121 (43.8%)   59/122 (48.4%)</span></span>
<span><span class="co">#&gt;   Weight                                                                     </span></span>
<span><span class="co">#&gt;     Low                      59/120 (49.2%)   54/117 (46.2%)   63/119 (52.9%)</span></span>
<span><span class="co">#&gt;     High                     58/123 (47.2%)   61/121 (50.4%)   55/113 (48.7%)</span></span></code></pre></div>
</div>
</div>
</div>
<div class="section level2">
<h2 id="listings">
<strong>LISTINGS</strong><a class="anchor" aria-label="anchor" href="#listings"></a>
</h2>
<div class="section level3">
<h3 id="glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms-ael01_nollt">
<strong>Glossary of Adverse Event Preferred Terms and
Investigator-Specified Terms (<code>AEL01_NOLLT</code>)</strong><a class="anchor" aria-label="anchor" href="#glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms-ael01_nollt"></a>
</h3>
<div class="section level4">
<h4 id="glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms">
<strong>1. Glossary of Adverse Event Preferred Terms and
Investigator-Specified Terms</strong><a class="anchor" aria-label="anchor" href="#glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>ael01_nollt</code></strong> template produces the
standard glossary of adverse event preferred terms and
investigator-specified terms.</li>
<li>The example below use <code>head</code> function to print only the
first 10 lines of the output.</li>
</ol>
<div class="sourceCode" id="cb53"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">l_ae_nollt</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ael01_nollt</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/utils/head.html" class="external-link">head</a></span><span class="op">(</span><span class="va">l_ae_nollt</span>, <span class="fl">10</span><span class="op">)</span></span>
<span><span class="co">#&gt; MedDRA System Organ Class   MedDRA Preferred Term   Reported Term for the Adverse Event</span></span>
<span><span class="co">#&gt; ———————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt; cl A.1                      dcd A.1.1.1.1                      trm A.1.1.1.1           </span></span>
<span><span class="co">#&gt;                             dcd A.1.1.1.2                      trm A.1.1.1.2           </span></span>
<span><span class="co">#&gt; cl B.1                      dcd B.1.1.1.1                      trm B.1.1.1.1           </span></span>
<span><span class="co">#&gt; cl B.2                      dcd B.2.1.2.1                      trm B.2.1.2.1           </span></span>
<span><span class="co">#&gt;                             dcd B.2.2.3.1                      trm B.2.2.3.1           </span></span>
<span><span class="co">#&gt; cl C.1                      dcd C.1.1.1.3                      trm C.1.1.1.3           </span></span>
<span><span class="co">#&gt; cl C.2                      dcd C.2.1.2.1                      trm C.2.1.2.1           </span></span>
<span><span class="co">#&gt; cl D.1                      dcd D.1.1.1.1                      trm D.1.1.1.1           </span></span>
<span><span class="co">#&gt;                             dcd D.1.1.4.2                      trm D.1.1.4.2           </span></span>
<span><span class="co">#&gt; cl D.2                      dcd D.2.1.5.3                      trm D.2.1.5.3</span></span></code></pre></div>
</div>
</div>
</div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="nest">
  <p>chevron is a part of the <strong>NEST</strong> and <a href="https://pharmaverse.org/" class="external-link"><strong>pharmaverse</strong></a>.</p>
</div>
<script type="text/javascript" src="../analytics.js"></script></footer>
</div>

  

  

  </body>
</html>
